Environmental sample testing device

Abstract

Detection devices, systems, and methods for detecting analytes in fluid samples are provided. The detection devices, systems, and methods can include colorimetric detection for rapidly determining the presence and / or amount of analytes obtained from surfaces contaminated or suspected of being contaminated with the analyte. In one aspect, the detection device includes a sample reservoir in fluid communication with a fluid flow path. The fluid flow path includes a control well downstream of the sample reservoir, a valve assembly downstream of the control well, a reagent well downstream of the valve assembly, and a test well downstream of the reagent well. In one aspect, the reagent well contains a dry reducing agent configured to generate a gas in the presence of a detection dye and an analyte in the fluid sample.

Description

[Technical Field]

[0001] (CROSS-REFERENCE TO RELATED APPLICATIONS) This application claims the benefit of U.S. Provisional Application No. 63 / 077,490, filed September 11, 2020, which is incorporated herein by reference in its entirety.

[0002] (Technical field) The present disclosure relates generally to detection devices, test systems, and methods. More particularly, the present disclosure relates to detection devices, including colorimetric detection devices, having a fluid flow path including one or more of a control well, a valve assembly, a reagent well, and a test well for detecting the presence and / or amount of an analyte in a sample. [Background technology]

[0003] Anti-tumor drugs are used to treat cancer and are often found as small molecules (such as fluorouracil) or antibodies (such as rituximab). Detection of anti-tumor drugs is essential to determine whether there is contamination or leakage in places where drugs are used and / or dispensed, such as hospitals and pharmacy areas.

[0004] The nature of antineoplastic drugs makes them harmful not only to cancer cells but also to healthy cells and tissues. Precautions must be taken to eliminate or reduce occupational exposure of healthcare workers to antineoplastic drugs. Pharmacists, who prepare these drugs, and nurses, who may prepare and administer them, are the two occupational groups most likely to be exposed to antineoplastic drugs. Furthermore, because patients treated with antineoplastic drugs may excrete these drugs, physicians and operating room personnel may also be exposed through patient care. Hospital personnel, such as shipping and receiving personnel, custodial personnel, laundry personnel, and waste disposal personnel, may also be exposed to these drugs in the course of their work. The increasing use of antineoplastic drugs in veterinary oncology also puts these workers at risk for exposure to these drugs. Summary of the Invention

[0005] Antineoplastic drugs have antiproliferative effects. In some cases, they affect the process of cell division by damaging DNA and initiating apoptosis, a type of programmed cell death. While this may be desirable to prevent the development and metastasis of neoplastic (e.g., cancer) cells, antineoplastic drugs can also affect rapidly dividing, non-cancerous cells. As such, antineoplastic drugs may suppress healthy biological functions, including bone marrow growth, healing, hair growth, and fertility, to name a few.

[0006] Studies have linked workplace exposure to anti-cancer drugs to health effects such as skin rashes, hair loss, infertility (both temporary and permanent), reproductive and fetal effects in pregnant women, genotoxic effects (e.g., disruptive effects on genetic material resulting in mutations), hearing impairment, and cancer. These health risks depend on the level of exposure and the potency and toxicity of the drug. While the potential therapeutic benefits of a drug may outweigh the risk of such side effects for ill patients, exposed healthcare workers risk the same side effects without the therapeutic benefit. Furthermore, exposure to anti-cancer drugs, even at low concentrations, is known to be hazardous to workers handling or working near them, and there is no safe exposure level for known carcinogens.

[0007] Embodiments of the detection device according to the present disclosure can detect the presence, absence, or amount of an analyte in an environmental sample on-site. While embodiments of the present disclosure are described in the context of detecting an analyte that is an anti-neoplastic agent, embodiments of the present disclosure can be implemented to detect any suitable analyte of interest. Test results can be provided quickly and on-site, alerting the test operator, other local personnel, and / or remote personnel to the presence and / or concentration of the anti-neoplastic agent close to the time of the test event. The testing method includes obtaining a sample from a surface contaminated or suspected to be contaminated with an anti-neoplastic agent. The sample can be obtained, for example, by contacting the surface with a buffer solution and wiping the surface with an absorbent cotton swab, or by wiping the surface with a cotton swab pre-wetted with the buffer solution. The collected contaminant (analyte) can be mixed with a test solution. The buffer solution along with the collected contaminant can be expressed or extracted from the swab to form a liquid sample. The liquid sample can be analyzed for the presence and / or amount of a specific anti-neoplastic agent. For example, a liquid sample can be added to a detection device described herein, which can then be read by a user or placed in a test system, such as a reader device, to identify the presence and / or concentration of an analyte in the liquid sample.

[0008] Some embodiments disclosed herein relate to a detection device for detecting an analyte in a liquid sample. In some embodiments, the detection device includes a sample reservoir in fluid communication with a fluid flow path. In some embodiments, the fluid flow path includes a control well downstream of the sample reservoir, a valve assembly downstream of the control well, a reagent well downstream of the valve assembly that includes a dried reducing agent, and a test well downstream of the reagent well.

[0009] In some embodiments, the reducing agent is configured to react with the detection dye in the presence of the analyte to initiate a color change. In some embodiments, the reducing agent is configured to generate a gas in the reagent well when the analyte is present in the fluid sample, the gas generated in the reagent well being configured to propel the fluid sample from the reagent well into the test well. In some embodiments, the reducing agent is NaBH4.

[0010] In some embodiments, the valve assembly includes a one-way valve configured to allow fluid samples and gases generated in the reagent well to travel from the reagent well toward the test well and to prevent fluid samples and gases generated in the reagent well from traveling upstream of the one-way valve.

[0011] In some embodiments, the sample reservoir contains a dried detection dye. In some embodiments, the detection dye is configured to solubilize in the fluid sample when the fluid sample is added to the sample reservoir, and the reducing agent is configured to react with the solubilized detection dye when an analyte is present in the fluid sample. In some embodiments, the fluid flow path includes a mixing feature downstream of the sample reservoir, and the mixing feature can include a plurality of posts disposed in the fluid flow path. In some embodiments, the plurality of posts is configured to promote mixing of the fluid sample with the detection dye when the fluid sample is added to the sample reservoir. In some embodiments, the detection dye is Direct Red 2, Direct Red 7, Direct Red 13, Direct Red 53, Direct Red 75, Direct Red 80, Direct Red 81, Direct Fast Red B, methylene blue, methyl orange, crocetin scarlet 7B, Congo red, or an azo dye. In some embodiments, the analyte is a platinum-based antitumor drug, including cisplatin, carboplatin, oxaliplatin, nedaplatin, triplatin tetranitrate, ormaplatin, phenanthriplatin, picoplatin, or satraplatin, or an analog or derivative thereof.

[0012] In some embodiments, the detection device further includes an overflow reservoir concentrically disposed around the sample reservoir. In some embodiments, the detection device further includes a cap, the cap including an outer seal and an activation plunger including an inner seal. In some embodiments, the activation plunger is configured to sealably couple with the sample reservoir and to propel a precise, predetermined volume of the fluid sample through the fluid flow path. In some embodiments, the detection device further includes a gas vent downstream of the test well, the gas vent configured to allow gas within the fluid flow path to exit the device after the fluid sample is added to the sample reservoir and begins to flow within the fluid flow path. In some embodiments, the gas vent includes a frit configured to seal against the passage of gas and the fluid sample in the presence of the fluid sample.

[0013] In some embodiments, the detection device further includes a top substrate having a portion of the fluid flow path and a bottom substrate having a portion of the fluid flow path, the fluid flow path further comprising a plurality of junction points when the top substrate is bonded to the bottom substrate, the plurality of junction points configured to move the fluid sample between the top substrate and the bottom substrate as fluid flows from the sample reservoir to the test well.

[0014] In some embodiments, the detection device further includes a housing including an observation window located above an upper surface of the test well and an upper surface of the control well, wherein when an analyte is present in the fluid sample, the optical signal read through the observation window from the test well is different from the optical signal read through the observation window from the control well.

[0015] In some embodiments, the detection device further includes a heating element substrate including a heat-activated reservoir, an upper surface of the heat-activated reservoir being substantially flush with an upper surface of the test well and an upper surface of the control well, and the housing further includes an access window located above the upper surface of the heat-activated reservoir, the heat-activated reservoir being configured to receive an activator through the access window. In some embodiments, the heating element substrate further includes a heating element cavity located below the test well and the control well, the heating element cavity including an exothermic material added to the heat-activated reservoir configured to generate heat when exposed to the activator. In some embodiments, the detection device further includes wicking paper including a first portion positioned in the heat-activated reservoir and a second portion positioned in the heating element cavity, the wicking paper being configured to wick at least a portion of the activator added to the heat-activated reservoir into the heating element cavity. In some embodiments, the thermally activated agent is air, water, a buffer, or a fluid, and the exothermic heating material comprises magnesium, iron, calcium chloride, calcium oxide, sodium acetate, paraffin, salt hydrates, fatty acids, other phase change materials, or combinations thereof. In some embodiments, the detection device further comprises a resistive heating element comprising a printed circuit board and an external power connector, wherein the printed circuit board comprises a plurality of resistive heating elements disposed below the reagent wells, the test wells, and the control wells.

[0016] Some embodiments disclosed herein relate to a method for detecting an analyte in a fluid sample. In some embodiments, the method includes applying the fluid sample to a sample reservoir of a detection device, solubilizing a detection dye in the sample reservoir in the fluid sample, propelling the fluid sample and the detection dye through a fluid flow path by attaching a cap to the sample reservoir, wherein the fluid sample and the solubilized detection dye flow sequentially to a control well, a valve assembly, and a reagent well, and generating a gas in the reagent well when the analyte is present in the fluid sample, the gas generated in the reagent well propelling the fluid sample from the reagent well to a test well. In some embodiments, the detection device includes a sample reservoir in fluid communication with the fluid flow path. In some embodiments, the fluid flow path includes a control well downstream of the sample reservoir, a valve assembly downstream of the control well, a reagent well downstream of the valve assembly, the reagent well containing a dried reducing agent, and a test well downstream of the reagent well.

[0017] In some embodiments, the reducing agent in the reagent well reacts with the solubilized detection dye in the fluid sample in the presence of the analyte in the fluid sample, initiating a color change in the fluid sample that is detectable in the test well.

[0018] In some embodiments, the method further includes mixing the fluid sample and the detection dye using a mixing feature disposed in the fluid flow path downstream of the sample reservoir. In some embodiments, the method further includes measuring a control signal in the control well, measuring a test signal in the test well, and indicating to a user that the analyte is not present in the fluid sample based on a determination that the control signal and the test signal are substantially the same. In some embodiments, the method further includes measuring a control signal in the control well, measuring a test signal in the test well, and indicating to a user that the analyte is present in the fluid sample based on a determination that the control signal and the test signal are different.

[0019] In some embodiments, the control signal is an optical signal having a first color, the test signal is an optical signal having a second, different color, and the fluid sample emits an optical signal having the second, different color as a result of reduction of the detection dye in the presence of a reducing agent and an analyte. In some embodiments, the detection dye is configured to change from the first color to the second, different color in the presence of a reducing agent and an analyte. In some embodiments, the reducing agent is NaBH4. In some embodiments, the fluid sample is applied to the sample reservoir in a volume of 100 to 500 μL. In some embodiments, the fluid sample is applied to the sample reservoir in a volume of about 250 μL. In some embodiments, the analyte is a platinum-based anti-tumor drug. In some embodiments, the platinum-based anti-tumor drug includes cisplatin, carboplatin, oxaliplatin, nedaplatin, triplatin tetranitrate, ormaplatin, phenanthriplatin, picoplatin, piriplatin, or satraplatin, or an analog or derivative thereof. In some embodiments, the method further includes heating the reagent wells and test wells using a heating element disposed below the reagent wells and test wells. In some embodiments, heating the reagent wells and test wells includes exposing the heating element disposed below the reagent wells and test wells to a thermally activated agent. In some embodiments, the method further includes adding a thermally activated agent to a thermally activated reservoir of the detection device and transferring the thermally activated agent from the thermally activated reservoir to a cavity containing an exothermic heating material. In some embodiments, the method further includes obtaining or obtaining a fluid sample from a surface contaminated or suspected of being contaminated with an analyte.

[0020] Some embodiments provided herein relate to a test system. In some embodiments, the test system includes a detection device for detecting an analyte in a fluid sample, a reader including a light source and a detector, and a data analyzer. In some embodiments, the detection device includes a sample reservoir in fluid communication with the fluid flow path. In some embodiments, the fluid flow path includes a control well downstream of the sample reservoir, a valve assembly downstream of the control well, a reagent well downstream of the valve assembly including a dried reducing agent, and a test well downstream of the reagent well. In some embodiments, the data analyzer is configured to output an indication that the analyte is not present in the fluid sample when the reader detects that the control signal measured in the control well is substantially the same as the test signal measured in the test well. In some embodiments, the data analyzer is configured to output an indication that the analyte is present in the fluid sample when the reader detects that the control signal measured in the control well is different from the test signal measured in the test well.

[0021] Some embodiments provided herein relate to a detection device for detecting an analyte in a fluid sample. In some embodiments, the detection device includes a sample reservoir in fluid communication with a fluid flow path, the fluid flow path including a control well downstream of the sample reservoir, a reagent well downstream of the control well and having a dried reducing agent, a test well downstream of the reagent well, and a one-way valve downstream of the control well and upstream of the reagent well, the one-way valve oriented to allow the fluid sample to pass from the control well toward the reagent well and to prevent the fluid sample from migrating upstream of the one-way valve.

[0022] In some embodiments, the detection device further comprises a top substrate including a portion of the fluid flow path and a bottom substrate including a portion of the fluid flow path. In some embodiments, the one-way valve is located at a junction where the top substrate is bonded to the bottom substrate along the fluid flow path. In some embodiments, the control well and the reagent well are located at least partially within the bottom substrate. In some embodiments, the fluid flow path traverses multiple junctions where the top substrate is bonded to the bottom substrate.

[0023] In some embodiments, the one-way valve is disposed at a third junction along the fluid flow path. In some embodiments, the one-way valve comprises a flapper valve having a normally closed configuration. In some embodiments, the flapper valve is oriented such that downstream fluid or gas pressure along the fluid flow path moves the flapper valve to an open configuration and upstream fluid or gas pressure along the fluid flow path seals the flapper valve against the valve inlet. In some embodiments, the flapper valve comprises an elastomeric element disposed between two substrate layers of the detection device. In some embodiments, the elastomeric element comprises a support ring and a moving flapper positioned to move at least partially into the flapper relief cavity in the presence of downstream fluid pressure.

[0024] In some embodiments, the detection device further comprises a cap, the cap comprising an outer seal and an activation plunger including an inner seal. In some embodiments, the activation plunger is configured to sealably couple with the sample reservoir and is configured to propel a precise volume of the fluid sample through the fluid flow path. In some embodiments, sealably coupling the activation plunger with the sample reservoir generates fluid pressure within the fluid sample sufficient to move the one-way valve to an open configuration.

[0025] In some embodiments, the reducing agent is configured to react with the detection dye in the presence of the analyte to initiate a color change. In some embodiments, the detection dye is located in the sample reservoir before the fluid sample is added to the detection device, and the detection dye is configured to initiate a change from a first color to a second, different color in the presence of the reducing agent and the analyte. In some embodiments, the reducing agent is configured to generate a gas in the reagent well when the analyte is present in the fluid sample, and the gas generated in the reagent well is configured to propel the fluid sample from the reagent well into the test well.

[0026] In some embodiments, the detection device further comprises a housing including an observation window positioned above an upper surface of the test wells and an upper surface of the control wells, wherein when an analyte is present in the fluid sample, an optical signal read from the test wells through the observation window differs from an optical signal read from the control wells through the observation window. In some embodiments, the detection device further comprises a heating element substrate including a heat-activated reservoir, wherein the housing further comprises an access window positioned above an upper surface of the heat-activated reservoir, the heat-activated reservoir configured to receive an activator through the access window. In some embodiments, the heating element substrate further comprises a heating element cavity positioned below the test wells and the control wells, the heating element cavity including an exothermic heating material configured to generate heat when exposed to an activator added to the heat-activated reservoir. In some embodiments, the detection device further comprises wicking paper including a first portion disposed within the heat-activated reservoir and a second portion disposed within the heating element cavity, the wicking paper configured to wick at least a portion of the activator added to the heat-activated reservoir into the heating element cavity.

[0027] In some embodiments, the detection device further comprises a resistive heating element including a printed circuit board and an external power connector, the printed circuit board including a plurality of resistive heating elements disposed beneath the reagent wells, the test wells, and the control wells. In some embodiments, the analyte is a platinum-based anti-tumor drug. In some embodiments, the platinum-based anti-tumor drug comprises cisplatin, carboplatin, oxaliplatin, nedaplatin, triplatin tetranitrate, ormaplatin, phenanthriplatin, picoplatin, piriplatin, or satraplatin, or an analog or derivative thereof.

[0028] Some embodiments provided herein relate to a detection device for detecting an analyte in a fluid sample. In some embodiments, the detection device includes a sample reservoir in fluid communication with a fluid flow path. The fluid flow path includes a reagent well containing a dried reducing agent, a test well downstream of the reagent well, and an overflow well downstream of the test well, the overflow well including a gas vent. The detection device further includes an overflow reservoir concentrically disposed around the sample reservoir.

[0029] In some embodiments, the detection device further includes a cap configured to cover the sample reservoir and the overflow reservoir. In some embodiments, the cap includes an activation plunger configured to sealably couple with the sample reservoir. In some embodiments, the sample reservoir is defined at least in part by a reservoir wall, and the activation plunger includes a circumferential seal having a size and shape corresponding to the interior size and shape of the reservoir wall. In some embodiments, sealably coupling the activation plunger with the sample reservoir pressurizes and propels a predetermined volume of fluid from the sample reservoir into the fluid flow path. In some embodiments, the predetermined volume corresponds to the total volume of fluid in the fluid flow path. In some embodiments, sealably coupling the activation plunger with the sample reservoir moves a portion of the fluid sample in the sample reservoir that exceeds the predetermined volume from the sample reservoir to the overflow reservoir. In some embodiments, the cap further includes an outer seal sized and shaped to engage with the overflow reservoir to retain fluid in the overflow reservoir when the cap covers the overflow reservoir. In some embodiments, closing the cap sealably isolates the overflow reservoir from the fluid flow path and from the exterior of the detection device.

[0030] In some embodiments, the analyte is a platinum-based antitumor drug, hi some embodiments, the platinum-based antitumor drug comprises cisplatin, carboplatin, oxaliplatin, nedaplatin, triplatin tetranitrate, ormaplatin, phenanthriplatin, picoplatin, piriplatin, or satraplatin, or an analog or derivative thereof.

[0031] In some embodiments, the gas vent is configured to allow gas within the fluid flow path to exit the detection device after a fluid sample is added to the sample reservoir and begins to flow within the fluid flow path, hi some embodiments, the gas vent comprises a frit configured to seal against the passage of gas and the fluid sample in the presence of the fluid sample.

[0032] In some embodiments, the reducing agent is configured to react with the detection dye to initiate a color change in the presence of the analyte. In some embodiments, the detection dye is located in the sample reservoir before the fluid sample is applied to the detection device, and the detection dye is configured to change from a first color to a second, different color in the presence of the reducing agent and the analyte. In some embodiments, the reducing agent is configured to generate a gas in the reagent well when the analyte is present in the fluid sample, and the gas generated in the reagent well is configured to propel the fluid sample from the reagent well into the test well.

[0033] In some embodiments, the fluid flow path further comprises a control well downstream of the sample reservoir, and the detection device further comprises a housing including an observation window located above an upper surface of the test well and an upper surface of the control well, wherein when an analyte is present in the fluid sample, an optical signal read from the test well through the observation window is different from an optical signal read from the control well through the observation window. In some embodiments, the detection device further comprises a heating element substrate including a heat-activated reservoir, and the housing further comprises an access window located above an upper surface of the heat-activated reservoir, the heat-activated reservoir configured to receive an activating agent through the access window. In some embodiments, the heating element substrate further comprises a heating element cavity located below the test well and the control well, the heating element cavity including an exothermic heating material configured to generate heat when exposed to an activating agent added to the heat-activated reservoir. In some embodiments, the detection device further comprises wicking paper including a first portion disposed within the heat-activated reservoir and a second portion disposed within the heating element cavity, the wicking paper configured to wick at least a portion of the activating agent added to the heat-activated reservoir into the heating element cavity.

[0034] In some embodiments, the detection device further comprises a resistive heating element including a printed circuit board and an external power connector, the printed circuit board including a plurality of resistive heating elements disposed below the reagent wells, the test wells, and the control wells.

[0035] Some embodiments provided herein relate to a method for testing a fluid sample using a detection device. In some embodiments, the method includes applying a fluid sample to a sample reservoir of a detection device, the fluid sample having a volume greater than a predetermined volume. The detection device includes a sample reservoir, a fluid flow path communicating with the sample reservoir and including at least a reagent well containing a dried reducing agent and a test well downstream of the reagent well, an overflow reservoir concentrically disposed around the sample reservoir, and a cap including an activation plunger sized and shaped to sealably engage within the sample reservoir. In some embodiments, the method further includes engaging the cap with the sample reservoir and applying pressure to the cap to propel a predetermined volume of the fluid sample into the fluid flow path.

[0036] In some embodiments, applying pressure to the cap simultaneously moves any portion of the fluid sample that exceeds the predetermined volume from the sample reservoir to the overflow reservoir. In some embodiments, applying pressure to the cap engages an outer seal of the cap with a wall of the overflow reservoir to prevent leakage of the fluid sample from the detection device. In some embodiments, the detection device further comprises a resistive heating element, and applying pressure to the cap causes the cap to activate a mechanical switch that activates the resistive heating element. [Brief explanation of the drawings]

[0037] [Figure 1A] FIG. 1 is a top view of an example of a detection device according to the present disclosure, with the cap in an open position exposing the sample reservoir. [Figure 1B] 1 is a top view of an example of a detection device according to the present disclosure, with the cap in a closed position. [Figure 2] FIG. 2 is a cross-sectional view illustrating a sample collection volume control feature of the exemplary detection device of FIG. 1A. [Figure 3]1B shows an exploded view of the exemplary detection device of FIG. 1A. [Figure 4A] 1 shows a top view of the fluid flow paths in an exemplary detection device in the absence of a fluid sample. [Figure 4B] 1 shows a top view of a fluid flow path in an exemplary detection device in the presence of a fluid sample. [Figure 5] FIG. 1B is an exploded view of the components of the exemplary detection device of FIG. 1A. [Figure 6A] 1B shows a top perspective view of the upper substrate of the exemplary detection device of FIG. 1A. [Figure 6B] 1B shows a top perspective view of the bottom substrate of the exemplary detection device of FIG. 1A. [Figure 7A] 1B illustrates an elastomeric element of a one-way valve of the exemplary detection device of FIG. 1A. [Figure 7B] 1B shows a cross-sectional view of the top substrate, one-way flapper valve, and bottom substrate of the exemplary sensing device of FIG. 1A. [Figure 8A] 1B illustrates an exploded view of the components of an integrated heating feature of an exemplary sensing device of the present disclosure, the integrated chemical heating element of the exemplary sensing device of FIG. 1A. [Figure 8B] 10 illustrates an integrated heating feature of an exemplary sensing device of the present disclosure, and an exemplary integrated electric heating feature of another exemplary sensing device of the present disclosure. [Figure 8C] 8C illustrates an integrated heating feature of an exemplary sensing device of the present disclosure, the integrated electrical heating feature separated from the housing of the exemplary sensing device of FIG. 8B. DETAILED DESCRIPTION OF THE INVENTION

[0038] Embodiments of the present disclosure relate to detection devices, test systems, and methods for measuring analytes. The embodiments of the detection devices, systems, and methods offer several advantages over existing devices, systems, and methods. For example, the devices deliver a specified, required volume of fluid sample to a detection device without the user needing to pre-measure the volume of the fluid sample before contacting the device. Thus, sample volume is automatically controlled, eliminating the need for the user to measure the sample volume, thereby eliminating or reducing user error. Additional advantages include pressure-driven fluid flow without requiring an external, specialized device to propel the sample through the fluid flow path; separation of a control region of a fluid flow path from a test region of the same fluid flow path; fluid flow paths that include one-way valves on two separate substrates to reduce artifacts in the control and test regions; and integrated heating features to control or expedite assay development. These and other advantages are discussed in detail in the detailed description below.

[0039] Platinum-based drugs are commonly used to treat patient-oncology malignancies via infusion, including lung, gastrointestinal, breast, and gynecological cancers. The primary testing site is associated with the infusion preparation space. Ease of use and accessibility allows testing of infusion sites and other monitoring sites of concern. Testing can be used to verify decontamination procedures, monitor drug preparation methods, or assess environmental contamination. The methods, systems, and devices disclosed herein enable on-location analysis, sampling, and testing for immediate results with minimal turnaround and reduced costs.

[0040] (sample collection volume control) Embodiments of the detection device can include sample collection volume control features. These features advantageously allow an operator to fill a reservoir with a fluid sample, eliminating the need to measure the exact volume of the fluid sample before adding it to the detection device. For example, a user does not need to pipette an exact volume or fluid sample into the detection device or count the number of drops of the fluid sample added to the detection device. The volume control feature includes a sample reservoir surrounded by an overflow reservoir. The sample reservoir is sized to deliver a predetermined volume of sample to the detection device, with excess liquid being captured by the surrounding overflow reservoir. The volume control feature also includes a cap with a plunger component. Capping the sample reservoir with this cap advantageously accomplishes three separate functions: (1) transferring excess liquid from the sample reservoir to the overflow reservoir; (2) directing a precise, predetermined volume of fluid sample into the fluid flow path of the detection device; and (3) sealing the sample reservoir and overflow reservoir, preventing fluid (which may contain harmful contaminants) from inadvertently spilling out of the device.

[0041] (Fluid pathway including internal pressure generation and artifact reduction) Optical systems that measure the presence or concentration of colored compounds in solution (colorimetry) are susceptible to artifacts in the test read area. Undesirable artifacts can include air bubbles and debris. Embodiments of the detection device can include fluidic flow paths and wells advantageously configured to reduce artifacts that can interfere with the detection of an analyte of interest in the test read area (in this case, the test well). The detection device can include a control well that can be fluidically isolated from the test well; an internal, self-contained gas pressure source that provides the driving force for propelling the fluid sample within the fluidic flow path; a one-way valve that prevents the fluid sample from backflowing through the fluidic flow path after gas pressure is generated; fluidic flow path features that reduce the formation of air bubbles within wells, including the test well; or any combination of these advantageous features. Features that reduce the formation of air bubbles include a fluidic flow path that fills the well from the bottom and a self-sealing vent that allows gas within the fluidic flow path to exit the detection device as the fluid sample flows through the fluidic flow path. Additional features that reduce the presence of air bubbles in the test well include surface modifications to the sidewalls of the wells where gas evolves to promote adhesion and surface modifications to the sidewalls of the test wells to promote wettability. As an example, when a gas is generated in a given reaction well, bubbles tend to form and adhere to the surface-modified sidewalls of the reaction well. This adhesion can prevent or minimize the migration of bubbles with the fluid sample to downstream test wells. The volumetric expansion of the gas in the reaction reservoir allows the sample to migrate relatively bubble-free into test wells with sidewalls treated to enhance wetting. The fluid sample migrated into the test well in this manner can be relatively artifact-free for clearer imaging within the test well.

[0042] Advantageously, the fluid sample flowing through the fluid flow path itself can reconstitute the dye and reducing agent. The reconstituted dye, if present, is used for colorimetric detection of the analyte in the fluid sample. Reconstitution of the reducing agent in the reaction well generates air or gas pressure, which moves the fluid sample into the test well. In this test well, a physical characteristic, such as color, of the test portion of the initial fluid sample can be compared with a physical characteristic, such as color, of a control portion of the same initial fluid sample. Using this internally generated air or gas pressure to fill the test well can prevent large air bubbles from forming in the test well, improving imaging of the assay results. Additionally, using this internally generated air or gas pressure to fill the test well can reduce sealing pressure. For example, the components forming the fluid flow path can be sealed together using mechanisms with relatively low fluid pressure tolerance compared to previous systems.

[0043] In one non-limiting embodiment of the present disclosure, a fluid sample is added to a collection well or sample reservoir of a detection device. The collection well can include various sample collection volume control features, as described above and in more detail below. The fluid sample in the collection well reconstitutes the dried dye present in the collection well. The fluid sample is driven through a mixing feature, to a control well, through a one-way valve, and to a reaction well. The mixing feature can facilitate mixing of the reconstituted dye and the fluid sample. The fluid sample in the reaction well reacts with a desiccant present in the reaction well, generating a gas. The desiccant can include, but is not limited to, a dry reducing agent, such as dry NaBH4. As the gas is generated in the reaction well, the fluid sample is forced into the test well. Once the test well is filled, the sample liquid flows to a feature that allows the passage of air moving ahead of the fluid sample as it travels through the fluid flow path, but seals in the presence of the fluid sample, thereby preventing the fluid sample from flowing out of the detection device. The sealing feature can include a self-sealing Porex frit.

[0044] (The control portion of the collected sample separated from the test portion of the collected sample) The detection devices of the present disclosure can incorporate control features to ensure valid and reliable assay test results. Embodiments of the detection device allow a single collected fluid sample to be added to the detection device at a single collection well, and for that single collected sample to be divided into a control portion and a test portion as the fluid sample travels through the device's internal fluid flow path (without further user intervention or action). Specifically, the fluid flow path includes features that separate a first portion of the fluid sample in the control well from a second portion of the fluid sample in the test well. The first or "control" portion and the second or "test" portion of the fluid sample are both derived from the same fluid sample added to the detection device at the collection well. When the fluid sample is added to the collection well, it first fills the control well, which is isolated from and not exposed to the reducing agent present in the detection device. Once the control well is filled, the fluid sample flows through a one-way valve into the reaction well, which contains the reducing agent. The one-way valve in the fluid path allows the sample to pass in one direction (from the control well to the reaction well) but seals against fluid and gas pressure. Meanwhile, the valve is sealed to prevent fluid or gas pressure from being applied in the opposite direction (from the reaction well toward the control well). The one-way valve can include a flapper valve that is normally closed and is opened by fluid pressure from the fluid sample passing through the valve. In the open state, the one-way valve can deflect only in one direction and seals against the valve inlet when back pressure is applied. Preventing backflow in this manner prevents contamination of the "control" portion of the fluid sample in the control well with the reducing agent and fluidically isolates the "control" portion of the fluid sample from the "test" portion of the fluid sample.

[0045] The fluid flow paths of the detection device can be formed using a two-substrate design. One-way valves can be implemented at the interface between the two substrates, each of which can be independently optimized during the fabrication of the detection device. Thus, the two-substrate design allows flexibility in material selection, surface treatment, color, and assembly method. For example, depending on the assay chemistry, collection wells can be included in the first substrate, which has a different surface treatment or material composition than the test wells included in the second substrate. The two-substrate design of the present disclosure allows the first and second substrates to be treated differently prior to assembly, allowing flexibility to meet the material requirements of the detection device.

[0046] Integrated heating features for heating the fluid sample within the fluid flow path Embodiments of the detection device can include integrated heating features for heating the fluid sample within the fluid flow path of the detection device. These integrated heating features advantageously optimize the onset time, amount, and location of heat applied to the interior of the detection device. Providing heat integrally using the embodiments described herein can advantageously shorten assay reaction times and / or provide ideal reaction temperatures without the need for additional external equipment to provide heat, such as environmental chambers or ovens.

[0047] The integrated heating can be provided by an exothermic chemical reaction that is activated when the activator is exposed to air, water, or other suitable elements. The heating component of the integrated chemical heating feature remains fully integrated and sealed within the housing of the detection device so that the detection device can be disposed of as waste at the end of the test event. Advantageously, the integrated chemical heating feature of the present disclosure does not require a power source, such as a battery.

[0048] In one non-limiting embodiment of the present disclosure, water is added to the reservoir at the beginning of the test procedure. The water is drawn into the cavity using a wicking layer (e.g., wicking paper), where it interacts with the exothermic substance present in the cavity. The wicking paper can control the flow of water into the cavity, thereby controlling the reaction rate between the water and the exothermic material. The exothermic material can include magnesium (Mg), which oxidizes in the presence of water and thermodynamically becomes a heat source. Sodium chloride (NaCl) and iron (Fe) can be included to kinetically enhance the reaction rate. A phase change material can be included in the integrated chemical heating feature to act as a buffer for the reaction so that the reaction temperature does not exceed a predetermined limit. The integrated chemical heating feature can be configured to generate heat at a precise time after activation and continue to generate heat at a specific temperature for a duration specific to the selected assay. The integrated chemical heating feature can contain chemicals that are non-toxic, safe, and disposable in standard waste streams.

[0049] Non-chemical integrated heating feature embodiments can also be implemented in the detection devices of the present disclosure, as described in more detail below. In one non-limiting example, a resistive heating element connected to a power source is housed in the same enclosure as the detection device. The integrated resistive heating element generates heat that is conducted to the portion of the detection device containing the fluid sample. The integrated resistive heating element can also be disposable in a waste stream that accepts battery chemistries.

[0050] Various embodiments are described below in conjunction with the drawings for purposes of illustration. It should be understood that many other embodiments of the disclosed concepts are possible, and that various advantages may be achieved in the disclosed embodiments. It will be understood that some, but not all, of the above-described features of sample collection volume control, internal pressure generation and artifact reduction, isolation of the control portion of the collected sample from the test portion, and integrated heating features may be implemented in a detection device according to the present disclosure.

[0051] Overview of an Exemplary Detection Device According to the Present Disclosure FIG. 1A illustrates an exemplary detection device 100 according to the present disclosure. The detection device 100 includes a bottom housing 110 and a top housing 120 that engage with each other and house the detection device components. The top housing 120 can include an observation window 122 for viewing and / or measuring signals in the control wells 160 and the test wells 150. The top housing 120 can include a heat-activation reservoir 170. The heat-activation reservoir 170 can receive a heat-activatable agent, such as a buffer, water, or any other heat-activatable agent capable of activating a heating element disposed within the detection device housing. The detection device 100 can include a gas vent 180 (shown in FIG. 6B). The gas vent 180 can allow air or gas to be vented from the fluid flow path of the detection device 100.

[0052] The detection device 100 further includes a cap 130. The cap 130 includes an outer seal 132, a plunger 134, and an inner seal 136. The cap 130 mates with a sample reservoir 212 of an upper substrate 210, which will be described in more detail below. The sample reservoir 212 includes a reservoir wall 214. The sample reservoir 212 may also include an overflow reservoir 216, which includes an overflow reservoir wall 218. The detection device 100 may also include one or more locking features 124 for engaging the cap 130.

[0053] 1B shows the exemplary detection device 100 with the cap 130 closed, such that a lip on the cap 130 engages the locking feature 124. In the closed position shown in FIG. 1B, the plunger 134 of the cap 130 engages the sample reservoir 212. The engagement of the plunger 134 with the sample reservoir 144 forces excess fluid sample in the sample reservoir 212 into the overflow reservoir 216. Furthermore, engaging the plunger 134 with the sample reservoir 212 generates pressure that propels the liquid sample through the fluid path of the detection device. The inner seal 136 of the plunger 134 engages with the reservoir wall 214. The plunger's inner seal 136 engages the reservoir wall 214, forcing excess liquid sample into the overflow reservoir 216 and forming a seal, generating pressure that forces the sample into the fluid path. The outer seal 132 of the cap 130 engages the overflow reservoir wall 218 , thereby preventing leakage of the liquid sample from the detection device 100 .

[0054] The interaction between the inner wall of the sample reservoir 212 and the outer surface of the plunger 134 is the mechanism for measuring a precise, predetermined volume of fluid sample and inputting that specific amount of fluid sample into the detection device 100. As a result, a user does not need to pre-measure the exact volume of fluid sample to be added to the sample reservoir 212. Instead, the user can apply an approximate volume of fluid sample to the sample reservoir 212. The act of closing the cap 130 engages the plunger 134 with the sample reservoir 212. As pressure on the cap 130 continues to be applied, moving the plunger 134 further into the sample reservoir 212, the portion of the fluid sample in excess of the predetermined volume moves from the sample reservoir 212 to the overflow sample reservoir 216, simultaneously propelling the exact required volume of liquid sample through the fluid flow path of the detection device 100. Advantageously, the excess liquid sample moved to the overflow sample reservoir 216 remains completely sealed within the detection device 100. Thus, embodiments of detection devices according to the present disclosure can avoid contamination of the surrounding environment and minimize the user's handling of excess liquid sample (which may contain harmful contaminants).

[0055] FIG. 2 shows a cross-sectional view of the sample collection volume control feature of the exemplary detection device 100 of FIGS. 1A and 1B. The cross-sectional view shows the bottom housing 110, the top housing 120, and the top substrate 210. The top substrate 210 will be described in more detail with reference to additional figures. When a fluid sample is placed in the sample reservoir 212, excess fluid sample flows from the sample reservoir 212 to the overflow reservoir 216. The outer surface of the plunger 134 (not shown in FIG. 2 but described above with reference to FIGS. 1A and 1B) engages the reservoir wall 214 of the sample reservoir 212, expelling excess liquid (as indicated by the arrow) onto the reservoir wall 214 and simultaneously forcing a precise, predetermined volume of the fluid sample into the fluid flow path along the fluid flow direction 221. An inner seal 136 of the plunger 134 (shown in FIG. 1A ) engages the reservoir wall 214 to control the removal of excess fluid sample from the sample reservoir 212 and also generates pressure to propel a precise, predetermined volume of the fluid sample into the fluid flow path in the direction of fluid flow 221. As mentioned above, the cap 130 of this embodiment also includes an outer seal 132 that engages the outer surface of the overflow reservoir wall 218 to prevent leakage of the fluid sample from the detection device 100.

[0056] In some embodiments of the detection device 100, the sample reservoir 212 has a volume of approximately 240 μL. In one non-limiting example, the predetermined volume of sample propelled from the sample reservoir 212 into the fluid flow path of the detection device 100 is approximately 240 μL. In this example, a reaction well (such as reaction well 140, described in more detail below) receives approximately 100 μL of sample. Advantageously, a user can provide a fluid sample having a volume approximating 240 μL by filling the sample reservoir 212 until the sample reaches the top surface 215 of the sample reservoir 212. When the cap 130 engages the sample reservoir 212, a portion of the sample volume in the sample reservoir 212 can spill over into the overflow sample reservoir 216. The plunger 134 of the cap 130 can be shaped and sized to ensure that a portion of the sample in the sample reservoir 212 overflows as it moves into the sample reservoir 216, providing a predetermined volume of sample (approximately 100 μL) through the flow path to the reaction well 140. In embodiments of the detection device 100, a user can provide a predetermined volume of sample to the detection device by adding sample to the sample reservoir 212 until the sample reaches the top surface 215 of the sample reservoir 212 and then engaging the cap 130 with the sample reservoir 212. The predetermined volume can correspond to the total volume of fluid in the fluid flow path.

[0057] The above-described sample collection volume control feature advantageously allows an operator to perform two simple steps (filling the sample reservoir 212 with a fluid sample and closing the cap 130), eliminating the need to measure the exact fluid sample volume before adding the fluid sample to the detection device. Sample collection volume control feature embodiments can significantly reduce a user's exposure to and handling of a collected fluid sample before adding it to the detection device. The sample collection volume control feature also minimizes a user's exposure to and handling of excess fluid sample that is transferred to the overflow sample reservoir 216. For example, a user can simply close the cap 130 of the detection device to initiate a test event, without having to remove or pipette excess fluid sample before initiating a test event. Furthermore, sample collection volume control feature embodiments seal a fluid sample that may contain hazardous contaminants within the detection device 100, thereby minimizing the risk of contamination of the surrounding environment.

[0058] FIG. 3 shows an exploded view of the exemplary detection device 100 of FIG. 1A. The detection device 100 includes a bottom housing 110, a top housing 120, and a cap 130, as described with reference to FIGS. 1A and 1B. Enclosed within the bottom housing 110 and the top housing 120 is a fluid flow path. The flow path can traverse one or more substrates, such as the top substrate 210 and the bottom substrate 310, as described in FIG. 2. As described in detail below, the top substrate 210 and the bottom substrate 310 can define a portion of the fluid flow path. The detection device 100 can also include a top layer 510. The top layer 510 seals two portions of the fluid flow path defined in the top substrate 210 (see surface channels 242, 256, described below with reference to FIG. 6A). The top layer 510 also seals portions of the test wells 150, control wells 160, and reagent wells 140 defined in the bottom substrate 310. In addition to sealing portions of the channels 242, 256 and wells 150, 160, and 140, the top layer 510 also seals portions of the channels 242, 256 and wells 150, 160, and 140 to confine the fluid sample to the detection device 100 when fluid is present within these structures. The top layer 510 can also seal the fluid flow path from exposure to the external environment. Advantageously, embodiments of the top layer 510 can be transparent to allow a user or detector to view the contents of the control wells 160 and test wells 150 through the observation window 122 in the upper housing 120. The transparency of the top layer 510 is illustrated in FIG. 3 , where features below the transparent top layer 510 are depicted with dashed lines. The detection device 100 can also include a heating element reservoir 170 configured to receive a thermally activated agent, which is described in more detail below with reference to FIG. 8A .

[0059] The bottom housing 110 and the top housing 120 may include mating features that align and couple the top housing 120 with the bottom housing 110. The mating features may include snap-fit ​​or press-fit features such as posts 111 and receptacles 112. The bottom housing 110 and the top housing 120 may also include mating features that align and couple the top substrate 210, the bottom substrate 310, and the heating element substrate 410 to the bottom housing 110 and the top housing 120. The mating features may facilitate alignment of the top housing 120 and the bottom housing 110 before pressing the housings together using a press-fit connection. For example, post 111A of bottom housing 110 can align and engage tab 113 of heating element substrate 410 and a receptacle (not shown) on the underside of the top housing, and post 111B of heating element substrate 410 can align and engage receptacle 112 of bottom substrate 310. The mating features can be properly aligned before the housings are coupled together to ensure that the internal components of detection device 100 engage with the housing in the proper orientation and prevent movement or displacement of the internal components during operation. Additional or different features can also be present to facilitate coupling of bottom housing 110 and top housing 120 in alignment with the internal components, including, but not limited to, lips, ledges, tabs, guides, or other suitable features.

[0060] An exemplary fluid flow path through the detection device 100 will now be described with reference to Figures 4A, 4B, 5, 6A, and 6B. Figure 4A illustrates an exemplary fluid flow path prior to application of a sample through the flow path, and Figure 4B illustrates the fluid flow path of Figure 4A after sample flow through the flow path. Figure 5 illustrates an exploded view of the top layer 510, top substrate 210, one-way valve components, bottom substrate 310, and lower layer 530 of the exemplary detection device 100. Figure 6A illustrates a top perspective view of the top substrate 210 and bottom substrate 310 of the detection device 100. Figure 6B illustrates a bottom perspective view of the top substrate 210 and bottom substrate 310 of the detection device 100. It will be understood that the layout, dimensions, and arrangement of the fluid flow paths are exemplary, and that other configurations can be implemented in accordance with the present disclosure.

[0061] An exemplary fluid flow path traverses the top substrate 210 and the bottom substrate 310, which are joined at junctions (described in detail below) to transition the flow path from one substrate to the other. Junctions 610, 612, and 614 are located in an overlapping region 616 where the top substrate 210 and the bottom substrate 310 are joined. The fluid flow path begins at the beginning 224 of the sample reservoir 212. As described above, the sample reservoir 212 includes a reservoir wall 214, an overflow reservoir 216, and an overflow reservoir wall 218. Within the sample reservoir 212 is a mobilizable detection dye 222. The dye 222 can be dried in place in the sample reservoir 212 during or after fabrication of the detection device. The dye 222 is configured to solubilize in a fluid sample when the sample is placed in the sample reservoir 212. The fluid sample having mobilized detection dye 222 therein is flowed or propelled by plunger 134 from sample reservoir 212 into the fluid flow path at starting point 224 .

[0062] The fluid flow path includes a mixing channel 226 that begins at a starting point 224 and extends to a point 228. In an embodiment of the present disclosure, fluid does not travel in direction 221 (shown in FIG. 2) along the mixing channel 226. In one example, the mixing channel 226 is dimensioned to prevent flow of sample from the sample reservoir 212 into the mixing channel 226 before the cap 130 is engaged.

[0063] As shown in FIG. 6B , the mixing channel 226 is defined by the bottom surface 230 of the top substrate 210 and a bottom layer 530. A portion of the bottom layer 530 is bonded to the bottom surface 230, and another portion of the bottom layer 530 is bonded to the bottom surface 320 of the bottom substrate 310. In one embodiment, the bottom layer 530 is a laminate material or film including a first side 532 and an opposing second side 534. After the top substrate 210 and the bottom substrate 310 are bonded as described above with reference to FIG. 1A , the first side 532 of the bottom layer 530 can be bonded or applied to the bottom surface 230 of the top substrate 210, can be bonded or applied to the bottom surface 320 of the bottom substrate 310, or can be bonded or applied to the bottom surface 230 of the top substrate 210. An adhesive may be bonded to or applied to the bottom surface 320 of the bottom substrate 310 to seal portions of the channels formed in the bottom surfaces of the top substrate 210 and the bottom substrate 310. In one example, an adhesive is applied to at least a portion 536 of a first side 532 of the bottom layer 530 to seal components of the top substrate 210, and an adhesive is applied to at least a portion 538 of the first side 532 to seal components of the bottom substrate 310. It will be appreciated that the bottom layer 530 may be bonded to or applied to the surface of the substrate in any suitable manner, including, but not limited to, applying adhesive to the side of the bottom layer 530, positioning adhesive between the bottom layer 530 and the surface of the substrate, and applying adhesive to the surface of the substrate.

[0064] A compressive force applied to the fluid sample by plunger 134 propels the fluid sample from starting point 224 into mixing channel 226. A plurality of posts 232 are arranged in mixing channel 226 in a configuration that forces the fluid to flow around posts 232 as it is propelled through mixing channel 226, thereby promoting mixing of the fluid sample with 222440. For example, the diverging and converging paths of the fluid around posts 232 can promote mixing of dyes within the fluid. In some instances, when the fluid sample reaches point 228, dye 222 and the fluid sample form a homogenous mixture. As described in more detail below, the reconstituted dye 222 mixed with the fluid sample, if present, is used in colorimetric detection of an analyte of interest in the fluid sample.

[0065] The fluid sample having the dye 222 mixed therein continues to flow through a mixing channel 226 defined in the top substrate 210 to a point 228 on the bottom surface 230 of the top substrate 210, as shown in Figure 6B. The fluid flow path continues through a lateral channel 234, which passes through the top substrate 210 between point 228 and point 236 on the top surface 240 of the top substrate 210, as shown in Figures 5 and 6A. The lateral channel 234 which passes through the top substrate 210 between point 228 and point 236 is illustrated by a dashed line in Figures 5, 6A, and 6B.

[0066] The lateral channels 234 connect to surface channels 242 located along the top surface 240 of the top substrate 210. Thus, the fluid flow path then continues into the top substrate 210 through the surface channels 242. The surface channels 242 are defined between the top surface 240 of the top substrate 210 and the top layer 510. In one example, the top layer 510 is a laminate material or film including a first side 512 and an opposing second side 514. The second side 514 of the top layer 510 can be bonded or applied to the top surface 240 of the top substrate 210 to seal the surface channels 242 formed in the top surface 240 of the top substrate 210. In one example, an adhesive is applied to at least a portion 516 of the second side 514 of the top layer 510. It will be appreciated that the top layer 510 can be bonded or applied to the surface of the substrate in any suitable manner, including, but not limited to, applying an adhesive to the sides of the top layer 510, positioning an adhesive between the top layer 510 and the surface of the substrate, and applying an adhesive to the surface of the substrate.

[0067] Surface channel 242 extends between point 236 and point 244. Point 244 of top substrate 210 connects to lateral channel 246. Lateral channel 246 passes through top substrate 210 from point 244 to point 248 on the underside 230 of top substrate 210, as shown in FIG. 6B. Thus, the fluid flow path then continues into top substrate 210 through lateral channel 246 between points 244 and 248. Lateral channel 246 passing through top substrate 210 between points 244 and 248 is illustrated by a dashed line in FIGS. 5 and 6A.

[0068] At point 248, the fluid flow transitions from the top substrate 210 to the bottom substrate 310 at a first junction 610. The first junction 610 is the location where the lateral channel 246 of the top substrate 210 fluidly connects with the lateral channel 322 of the bottom substrate 310. The first junction 610 can be formed when the top substrate 210 and the bottom substrate 310 are aligned and bonded such that point 248 of the lateral channel 246 of the top substrate 210 is fluidly coupled to point 324 of the lateral channel 322 of the bottom substrate 310. Thus, the first junction 610 transitions the fluid flow path from the top substrate 210 to the bottom substrate 310.

[0069] 6A and 6B, the bottom surface 230 of the top substrate 210 includes a first seal rim 250 formed around point 248. The top surface 330 of the bottom substrate 310 includes a seal recess 332 formed around point 324. By bonding the top substrate 210 and the bottom substrate 310 as described above with reference to FIG. 1A, the first seal rim 250 can be sealingly bonded to the seal recess 332. Any fluid leakage at the first bond point 610 can be prevented or inhibited. It will be understood that these seal features are optional and other seal configurations can be implemented.

[0070] The lateral channel 322 connects to the surface channel 334 at point 336, which is located on the bottom surface 320 of the bottom substrate 310. The lateral channel 322, which passes through the bottom substrate 310 between point 324 and point 336, is illustrated by a dashed line in FIGS. 5, 6A, and 6B. The fluid flow path then continues into the bottom substrate 310 through the surface channel 334. The surface channel 334 is defined between the bottom surface 320 of the bottom substrate 310 and the bottom layer 530. As discussed above, in one example, the bottom layer 530 is a laminate material or film including a first side 532 and an opposing second side 534. In one non-limiting example, an adhesive is applied to at least a portion 538 of the first side 532. A first side 532 of the bottom layer 530 may be bonded or applied to the bottom surface 320 of the bottom substrate 310 and seal the surface channels 334 formed in the bottom surface 320 of the bottom substrate 310 .

[0071] Surface channel 334 extends between point 336 and control well 160. Thus, the fluid flow path continues along surface channel 334 until surface channel 334 intersects with control well 160 at point 338 on bottom surface 320 of bottom substrate 310. Control well 160 is defined within bottom substrate 310 between two layers that are bonded to the top and bottom surfaces of bottom substrate 310. In this example, control well 160 is defined by a generally cylindrically shaped passage within bottom substrate 310, with top surface 340 of control well 160 defined by portion 518 of top layer 510 and bottom surface 342 of control well 160 defined by portion 538 of bottom layer 530. It will be understood that other configurations for forming control well 160 are possible.

[0072] The fluid sample begins to fill the control well 160 and enters the control well 160 at point 338. As shown in FIG. 6B, point 338 is fluidly connected to the control well 160 at the bottom of the control well 160. Thus, in embodiments of the present disclosure, the control well 160 is filled with the fluid sample from the bottom to the top of the control well 160. The top layer 510 can be transparent so that the presence of the fluid sample in the control well 160 can be visualized through the top layer 510, which forms the top surface 340 of the control well 160. Furthermore, the sealed top surface 340 of the control well 160 aligns with the observation window 122 of the upper housing 120. Advantageously, this arrangement allows a dye in the fluid sample in the control well 160 to be measured and detected through the observation window 122. In some embodiments, the dye is a colorimetric dye and the measurement is colorimetric.

[0073] Thus, embodiments of detection device 100 allow a user to confirm that the fluid sample (mixed with dye 222 as described above) has flowed from sample reservoir 212 to control well 160 by visually verifying whether the stained fluid sample is visible in the control well through observation window 122. This visual evaluation of control well 160 at this point in the test event allows a user to confirm that detection device 100 is operating as intended. Furthermore, embodiments of detection device 100 advantageously fill control well 160 from the bottom to the top of the well, causing any air present in control well 160 to be displaced to the top of control well 160 as the well fills with fluid sample. As a result, the introduction of undesirable air bubbles into the fluid sample as it passes through control well 160 is minimized, thereby improving colorimetric measurement of the portion of the fluid sample that flows into test well 150.

[0074] The fluid flow path then travels from the control well 160 to a lateral channel 344 at point 346 located on the upper surface 330 of the bottom substrate 310. When the fluid sample reaches the upper surface 340 of the control well 160, the fluid sample travels through a portion 348 of the control well 160 to point 346, and then back down the bottom substrate 310 through lateral channel 344. Thus, the fluid flow path travels away from the upper surface 330 of the bottom substrate 310 and towards the lower surface 320 of the bottom substrate 310.

[0075] The lateral channel 344 connects to the surface channel 350 at point 352, which is located on the bottom surface 320 of the bottom substrate 310. The lateral channel 344, which passes through the bottom substrate 310 between point 346 and point 352, is illustrated by a dashed line in FIGS. 5 and 6A . The fluid flow path then continues into the bottom substrate 310 through the surface channel 350. The surface channel 350 extends between point 352 and point 354 on the bottom surface 320 of the bottom substrate 310. The surface channel 350 is defined between the bottom surface 320 of the bottom substrate 310 and a bottom layer 530. As discussed above, in one example, the bottom layer 530 is a laminate material or film including a first side 532 and an opposing second side 534. In one non-limiting example, an adhesive is applied to at least a portion 538 of the first side 532. A first side 532 of the bottom layer 530 may be bonded or applied to the bottom surface 320 of the bottom substrate 310 to seal the surface channels 350 formed in the bottom surface 320 of the bottom substrate 310 .

[0076] Point 354 of bottom substrate 310 connects to lateral channel 356. Lateral channel 356 penetrates bottom substrate 310 between point 354 and point 358 on top surface 330 of bottom substrate 310, as shown in Figures 5 and 6A. Lateral channel 356 passing through bottom substrate 310 between points 354 and 358 is shown by a dashed line in Figures 5, 6A, and 6B. Thus, the fluid flow path then continues into bottom substrate 310 through lateral channel 356 between points 354 and 358.

[0077] At point 358, the fluid flow transitions from the bottom substrate 310 back to the top substrate 210 at second junction 612. The second junction 612 is the location where the lateral channel 356 of the bottom substrate 310 fluidly connects with the lateral channel 252 of the top substrate 210. The second junction 612 can be formed when the top substrate 210 and the bottom substrate 310 are aligned and bonded such that point 358 of the lateral channel 356 of the bottom substrate 310 is fluidly coupled to point 254 of the lateral channel 252 of the top substrate 210. Thus, the second junction 612 transitions the fluid flow path from the bottom substrate 310 to the top substrate 210.

[0078] 6A and 6B, the bottom surface 230 of the top substrate 210 includes a second seal rim 250 formed around point 254. The top surface 330 of the bottom substrate 310 includes a second seal recess 332 formed around point 358. By bonding the top substrate 210 and the bottom substrate 310 as described above with reference to FIG. 1A, the second seal rim 250 can be sealingly bonded to the second seal recess 332. Any fluid leaking at the second bond point 612 can be prevented or contained. It will be understood that these sealing features are optional and other seal configurations can be implemented.

[0079] The lateral channel 252 connects to the surface channel 256 at point 258, which is located on the top surface 240 of the upper substrate 210. The lateral channel 252, which passes through the top substrate 210 between point 254 and point 258, is illustrated by a dashed line in FIGS. 5 and 6A . The fluid flow path then continues into the top substrate 210 through the surface channel 256. The surface channel 256 extends between point 258 and point 260 on the top surface 240 of the top substrate 210. The surface channel 256 is defined between the top surface 240 of the top substrate 210 and the top layer 510. As explained above, in one example, the top layer 510 is a laminate material or film including a first side 512 and an opposing second side 514. In one non-limiting example, an adhesive is applied to at least a portion 516 of the second side 514. The second side 514 of the top layer 510 may be bonded or applied to the top surface 240 of the top layer substrate 210 to seal the surface channels 256 formed in the top surface 240 of the top layer substrate 210 .

[0080] Point 260 on top substrate 210 connects to lateral channel 262. Lateral channel 262 passes through top substrate 210 between point 260 and point 264 on the lower surface 230 of top substrate 210, as shown in Figure 6B. Thus, the fluid flow path then continues into top substrate 210 through lateral channel 262 between points 260 and 264. Lateral channel 262 passing through top substrate 210 between points 260 and 264 is illustrated by a dashed line in Figures 5, 6A, and 6B.

[0081] At point 264, the fluid flow transitions from the top substrate 210 back to the bottom substrate 310 at third junction 614. The third junction 614 is the location where the lateral channel 262 in the top substrate 210 fluidly connects with the lateral channel 360 in the bottom substrate 310. The third junction 614 can be formed when the top substrate 210 and the bottom substrate 310 are aligned and bonded such that point 264 of the lateral channel 262 in the top substrate 210 is fluidly coupled to point 362 of the lateral channel 360 in the bottom substrate 310. Thus, the third junction 614 transitions the fluid flow path from the top substrate 210 to the bottom substrate 310.

[0082] In one embodiment, the lower surface 230 of the top substrate 210 includes a third seal rim 250 formed around point 264, and the upper surface 330 of the bottom substrate 310 includes a third seal recess 332 formed around point 362. By bonding the top substrate 210 and the bottom substrate 310 as described above with reference to FIG. 1A , the third seal rim 250 can be sealingly bonded to the third seal recess 332. Any fluid leaking at the third junction 614 can be prevented or inhibited. It will be understood that these sealing features are optional and other sealing configurations can be implemented.

[0083] Embodiments of the detection device 100 can include a one-way valve 700 at the third junction 614. In one non-limiting aspect, the one-way valve is a flapper valve including a surface 266 within the third seal rim 250 of the top substrate 210, the flapper valve including the surface 266 within the third seal rim 250 of the top substrate 210, the flapper relief cavity 364 in the bottom substrate 310, and an elastomeric element 710. An optional support structure 750 may also be included in the flapper valve assembly. At the third junction 614, a fluid flow path runs from the top substrate 210, through the flapper valve 700, and to the bottom substrate 310. 7A and 7B , the one-way flapper valve only allows material (such as a fluid sample or gas generated in the detection device 100) to flow in this one direction (from the top substrate 210 to the lateral channel 360 of the bottom substrate 310) at the third junction 614, but does not allow material to flow back in the opposite direction (from the bottom substrate 310 to the lateral channel 262 of the top substrate 210). Thus, the one-way flapper valve 700 allows gas or liquid to flow in one direction through the third junction 614 (downstream toward the reagent wells 140), but does not allow gas or liquid to flow back through the third junction 614 (upstream from the reagent wells 140 toward the control wells 160).

[0084] Embodiments of the detection device 100 including the one-way valve 700 at the third junction 614 can advantageously maintain unidirectional flow of the fluid sample through the fluid flow path of the detection device 100. In addition to controlling fluid and gas flow at the third junction 614, the one-way valve 700 can ensure unidirectional flow of fluid at other locations within the fluid flow path. The generation of gas at a location in the detection device 100 downstream of the third junction 614 can change internal pressure or create vacuum conditions at various locations within the fluid flow path of the detection device 100. These pressures or vacuum conditions can act on portions of the fluid sample to cause them to flow backward (upstream) through the fluid flow path rather than forward (downstream). It has been found that the one-way valve 700 at the third junction 614, in conjunction with pressure exerted on the fluid sample by the plunger 134, can move a predetermined, precise amount of fluid sample through the flow path from the sample reservoir 212 to the test well 150 in a predictable and consistent manner.

[0085] After passing through the one-way flapper valve 700 at the third junction 614, the fluid flow path continues to point 362, where it enters a lateral channel 360 in the bottom substrate 310. The lateral channel 360 connects to a surface channel 366 at point 368, located on the bottom surface 320 of the bottom substrate 310. The lateral channel 360 passing through the bottom substrate 310 between points 362 and 368 is illustrated by dashed lines in FIGS. 5 and 6B. The fluid flow path then continues into the bottom substrate 310 through the surface channel 366. The surface channel 366 is defined between the bottom surface 320 of the bottom substrate 310 and the layer 530. As discussed above, in one example, the bottom layer 530 is a laminate material or film including a first side 532 and an opposing second side 534. In one non-limiting example, an adhesive is applied to at least a portion 538 of the first side 532. A first side 532 of the bottom layer 530 is bonded or applied to the bottom surface 320 of the bottom substrate 310 and seals the surface channel 366 formed in the bottom surface 320 of the bottom substrate 310 .

[0086] Surface channel 366 extends between point 368 and reagent well 140. Thus, the fluid flow path continues along surface channel 366 until surface channel 366 intersects with reagent well 140 at point 370 on bottom surface 320 of bottom substrate 310. Reagent well 140 is defined within bottom substrate 310 between two layers that are bonded to the top and bottom surfaces of bottom substrate 310. In this example, reagent well 140 is generally defined by a passage within bottom substrate 310. Top surface 372 of reagent well 140 is defined by portion 518 of top layer 510, and bottom surface 374 of reagent well 140 is defined by portion 538 of bottom layer 530. It will be appreciated that other configurations for forming reagent well 140 are possible.

[0087] The fluid sample begins to fill the reagent well 140 and enters the reagent well 140 at a point 370. As shown in FIG. 6B , point 370 is fluidly connected to the reagent well 140 at the bottom of the reagent well 140. Thus, in embodiments of the present disclosure, the reagent well 140 is filled with the fluid sample from the bottom to the top of the reagent well 140. The top layer 510 can be transparent so that the presence of the fluid sample in the reagent well 140 can be seen through the top layer 510 that seals the top surface 372 of the reagent well 140. Furthermore, the sealed top surface 372 of the reagent well 140 is aligned with the observation window 122 of the upper housing 120. Advantageously, this arrangement allows the dye 222 in the fluid sample in the reagent well 140 to be measured and detected through the observation window 122. In some embodiments, the dye is a colorimetric dye and the measurement is a colorimetric measurement.

[0088] Thus, embodiments of detection device 100 allow a user to confirm that the fluid sample (mixed with dye 222 as described above) has flowed from sample reservoir 212 to reagent well 140 by visually verifying whether the stained fluid sample is visible in the control well through observation window 122. This visual assessment of reagent well 140 at this point in the test event allows a user to confirm that detection device 100 is operating as intended. Furthermore, embodiments of detection device 100 advantageously fill reagent well 140 from the bottom to the top of the well. Any air present in reagent well 140 is displaced to the top of reagent well 140 as the well fills with fluid sample. As a result, the introduction of undesirable air bubbles into the fluid sample as it passes through reagent well 140 is minimized, thereby improving colorimetric measurement of the portion of the fluid sample that flows into test well 150.

[0089] The reagent well 140 contains a reducing agent 142. The reducing agent 142 can be added to the reagent well 140 during fabrication of the detection device. The reducing agent 142 is configured to react with the solubilized detection dye 222 in the presence of an analyte in the fluid sample in the reagent well 140. If the fluid sample in the reagent well 140 does not contain the analyte, the reducing agent 142 does not react with the solubilized detection dye 222. The reducing agent 142 can be added to the reagent well 140 during fabrication of the detection device. For example, the reducing agent 142 can be dried in the reagent well 140 during fabrication of the detection device 100. In some cases, the reducing agent 142 is added to the reagent well 140 before the top layer 510 is bonded to the top substrate 210 and the bottom substrate 310. When the reducing agent 142 reacts with the dye 222 in the presence of the analyte of interest, the reaction generates a gas and causes the detection dye 222 to change color. As described above and in more detail below, the generation of gas in reagent well 140 advantageously propels the fluid sample into test well 150 in a manner that reduces undesirable artifacts, such as air bubbles, in the fluid sample in the test well. Furthermore, a change in the physical properties of the dye in the presence of the analyte of interest (in this case, the dye changes from a first color (observed in control well 160) to a second color (observed in test well 150)) allows the presence (and, in some cases, the amount) of the analyte in the fluid sample to be detected in test well 150.

[0090] Accordingly, embodiments of detection device 100 advantageously include an internal mechanism for propelling the fluid sample between reagent well 140 and test well 150, where the internal mechanism is not activated unless and until the fluid sample reaches reagent well 140. In particular, gas generated by the reaction of reducing agent 142 with dye 222 propels the fluid sample through the remainder of the fluid flow path, particularly from reagent well 140 to test well 150.

[0091] The fluid flow path travels from the reagent well 140 to a lateral channel 376 at point 378 located on the upper surface 330 of the bottom substrate 310. When the fluid sample reaches the upper surface 372 of the reagent well 140, the fluid sample flows through a portion 380 of the reagent well 140 to point 378, and then flows back down the bottom substrate 310 through the lateral channel 376. Thus, the fluid flow path travels away from the upper surface 330 of the bottom substrate 310 and toward the lower surface 320 of the bottom substrate 310.

[0092] Lateral channel 376 extends between point 378 and point 382, ​​which is located on bottom surface 320 of bottom substrate 310. Lateral channel 376, which passes through bottom substrate 310 between points 378 and 382, ​​is shown by a dashed line in FIGS. 5 and 6B. Portion 384 of test well 150 extends between point 382 and the entrance to test well 150. Thus, a fluid flow path continues from point 382, ​​along portion 384 of test well 150, and into test well 150. Test well 150 is defined within bottom substrate 310 between two layers bonded to the top and bottom surfaces of bottom substrate 310. In this example, test well 150 is defined by a cylindrical passage within bottom substrate 310. A top surface 386 of test well 150 is defined by portion 518 of top layer 510, and a bottom surface 388 of test well 150 is defined by portion 538 of bottom layer 530. It will be appreciated that other configurations for forming the test wells 150 are possible.

[0093] The fluid sample begins to fill the test well 150 and enters the test well 150 at point 382. As shown in FIG. 6B , point 382 is fluidly connected to the test well 150 at the bottom of the test well 150. Thus, in embodiments of the present disclosure, the test well 150 is filled with the fluid sample from the bottom to the top of the test well 150. The top layer 510 can be transparent so that the presence of the fluid sample in the test well 150 can be seen through the top layer 510, which seals the top surface 386 of the test well 150. Furthermore, the sealed top surface 386 of the test well 150 aligns with the observation window 122 of the upper housing 120. Advantageously, this arrangement allows a dye in the fluid sample in the test well 150 to be measured and detected through the observation window 122. In some embodiments, the dye is a colorimetric dye and the measurement is colorimetric. As described above, the dye 222 of the fluid sample entering the test well 150 changes color in the presence of the reducing agent 142 and the analyte in the fluid sample within the reagent well 140. This color change of the dye 222 can be observed through the top layer 510 sealing the top surface 386 of the test well 150 and is visible through the observation window 122.

[0094] Thus, in embodiments of detection device 100, a user can visually confirm that the fluid sample (mixed with dye 222, as described above) has flowed from sample reservoir 220 into test well 150 by visually verifying whether the stained fluid sample is visible in test well 150 through observation window 122. This visual assessment of test well 150 at this point in the test event allows the user to confirm that detection device 100 is operating as intended. Furthermore, embodiments of detection device 100 advantageously fill test well 150 from the bottom to the top of the well. In this manner, air present in test well 150 is displaced from the top of test well 150 as the well fills with fluid sample. As a result, the introduction of undesirable air bubbles into the fluid sample as it fills test well 150 is minimized, thereby improving colorimetric measurement of the portion of the fluid sample present in test well 150.

[0095] Accumulation of the fluid sample in the test wells 150 allows for measurement of a characteristic, such as color, of the fluid sample in the test wells 150. The colorimetric measurement of the fluid sample in the test wells 150 can be compared to a colorimetric measurement of the fluid sample in the control wells 160. The colorimetric measurement can include measuring image pixel intensities in the test wells 150 and the control wells 160. In one non-limiting embodiment, if the analyte is present in the fluid sample, a color shift in the form of decolorization (e.g., a decrease in optical density at an observation wavelength) is measured. In an alternative non-limiting embodiment, a wavelength shift is measured. In this example, if the analyte is present in the fluid sample, the wavelength of the detected signal in the test wells 150 is different from the wavelength of the detected signal in the control wells 160. The wavelength difference can be analyzed to determine the presence and / or amount of the analyte in the sample. It will be understood that embodiments of the present disclosure can implement measurement of a color shift (e.g., a decrease in optical density at an observed wavelength), a wavelength shift, or a change in any other suitably observable characteristic.

[0096] For a portion of the fluid sample, the fluid flow path can continue from the test well 150 to an overflow well 394 that includes a gas vent 180 and a sealing frit 390, such as a sealing Porex®. As shown in FIG. 5 , a portion of the bottom layer 530 can include a cutout 537 in the area below the gas vent 180. The portion of the bottom layer 530 can include a cutout 537 in the area below the gas outlet 180 so that the bottom layer 530 does not seal the gas outlet 180 and allows gas to be released into the device housing. The frit 390 can be a self-sealing frit that allows gas within the fluid flow path to pass through the frit and exit the detection device to the external environment, but seals against the passage of gas and fluid in the presence of fluid. The overflow well 394 can be fluidly connected to the top surface of the test well 150 via portion 392. The top surface of overflow well 394 can be sealed by portion 518 of top layer 510, as described above with reference to top surface 386 of test well 150. When the fluid sample reaches the top surface of test well 150, a portion of the fluid sample can flow through portion 392 into overflow well 394. The portion of the fluid sample can interact with frit 390 disposed within the overflow well.

[0097] Advantageously, frit 390 can serve multiple functions in detection device 100. The flow of the fluid sample through the fluid flow path displaces gas that was present within the fluid flow path. This displaced gas flows through the fluid flow path ahead of the fluid sample to gas vent 180. Frit 390 can allow the displaced gas to exit detection device 100, thereby preventing the displaced gas from becoming pressurized within the fluid flow path and impeding the flow of the fluid sample through the fluid flow path of detection device 100. Additionally, frit 390 prevents the passage of the fluid sample out of detection device 100, thereby ensuring that any portion of the fluid sample that exits test well 150 is retained within detection device 100.

[0098] 4B, the path and direction of the fluid sample through the fluid flow path is indicated by arrows. Solid arrows represent the flow of the fluid sample from sample reservoir 212, through control well 160, and to one-way valve 700. After the fluid sample passes through one-way valve 700, the flow of the fluid sample is represented by dashed arrows, which represent the fluid sample passing through one-way valve 700 and thus on the test side of detection device 100. Control well 160 is depicted with a different pattern than that of reagent well 140 and test well 150, which represents a difference in the color of the fluid sample and, therefore, the difference in the optical signal that would be detected in control well 160 compared to test well 150 if the analyte is present in the fluid sample.

[0099] 5 is an exploded view of the components of the detection device 100. As described above, the detection device 100 includes a fluid flow path that can traverse the top substrate 210 and the bottom substrate 310 by passing through transition or junction points, allowing a fluid sample to travel back and forth between the top substrate 210 and the bottom substrate 310. It will be understood that this is an exemplary fluid flow path, and other flow paths can be suitably implemented. For example, the fluid flow path can begin at the bottom substrate 310, transition to the top substrate 210, and then descend to the bottom substrate 310. As another example, fewer or more junction points can be implemented.

[0100] The fluid flow path has two distinct and separate sides: a control side upstream of the one-way valve 700 and a test side downstream of the one-way valve 700. It will be understood that the term "downstream" refers to the direction of fluid flow when the detection device 100 is operating as intended, and does not necessarily refer to fluid flowing in a downward direction. As explained above, there is a downstream portion of the fluid flow path where fluid flows upward from the bottom substrate 310 to the top substrate 210. A portion of the one-way valve 700 fits within the flapper relief cavity 364, which only allows fluid sample flow in the downstream direction after passing through the valve 700. The fluid sample flows downstream to the reagent wells 140 and test wells 150, but does not flow in the opposite direction toward the control well 160. Additionally, as described above, portions of the fluid flow paths are sealed from the external environment by a top layer 510 in contact with the top substrate 210 and the bottom substrate 310, and by a bottom layer 530 in contact with the bottom substrate 310 and the top substrate 210. Advantageously, the top layer 510 can be transparent so that physical properties such as color of the fluid sample can be measured and detected in the control wells 160 and the test wells 150.

[0101] 6A shows an exploded top view of the top substrate 210 and bottom substrate 310 of the detection device 100. FIG. 6B shows an exploded bottom view of the bottom substrate 310 and top substrate 210 of the detection device 100. These exploded views depict portions of the fluid flow paths including mixing features, features forming junctions 610, 612, and 614, control wells 160, one-way valve features, reagent wells 140, and test wells 150.

[0102] FIG. 7A illustrates an exemplary elastomeric element 710 of a flapper valve 700 of the detection device 100. The elastomeric element 710 includes a moving flapper 720 and a support ring 730. FIG. 7B illustrates a cross-sectional view of a one-way valve assembly of the detection device 100, including the elastomeric element 710 of FIG. 7A. A fluid sample flows unidirectionally through the one-way valve 700 from the top substrate 210 to the bottom substrate 310. Fluid pressure from the fluid sample flowing through the valve 700 moves the moving flapper 720 into a flapper relief cavity 364, which is a recess formed in the bottom substrate 310. Movement of the flapper 720 into the flapper relief cavity 364 fills the flapper relief cavity 364, allowing the fluid sample to pass through the lateral channel 360 of the bottom substrate 310. Once the fluid sample passes through the valve 700 and into the lateral channel 360, the moving flapper 720 returns to its non-moving state due to its elastomeric properties. A support ring 730 supports and holds the moving flapper 720 in its non-moving and moving states by the top substrate 210 and bottom substrate 310. The one-way flapper valve 700 is sealed to the top substrate 210 along a sealing surface 740, which serves to prevent flow of the fluid sample in a direction opposite the intended fluid flow direction. It will be understood that other suitable valves can be implemented in the detection device 100.

[0103] (Example of an integrated heating feature on a sensing device) Exemplary integrated heating elements that can be implemented in the detection devices of the present disclosure are described next. While the exemplary integrated heating elements are described with reference to detection device 100, the integrated heating element aspects of the present disclosure may be suitably implemented in any test or detection device in which it is desirable to include an internal or self-contained heat source. It will also be understood that the detection devices of the present disclosure may be suitably implemented without an integrated heating element. Furthermore, in detection device embodiments that implement an integrated heating element, it will be understood that the integrated heating element may include any material capable of generating heat. For example, the heating element may be a chemical heating element, a resistive heating element, or any other suitable heating element.

[0104] FIG. 8A shows an exploded view of the components of an exemplary integrated chemical heating element of detection device 100. As described above, detection device 100 includes top substrate 210 (e.g., as shown in FIG. 5), bottom substrate 310, top layer 510, and bottom layer 530. Detection device 100 also includes the following features disposed below bottom layer 530: white background material 810, sheet 820, seal 830, heating element substrate 410, heating element 840, wicking layer (e.g., wicking paper) 850, and layer 870 comprising a pressure-sensitive adhesive (PSA). White background material 810 is disposed below bottom layer 530 and can provide a reproducible background for imaging assay results in test wells 150 and control wells 160. Although not shown in FIG. 8A, detection device 100 also includes bottom housing 110 and top housing 120, which are shown in FIG. 1A. When coupled together, the bottom housing 110 and the top housing 120 form an enclosure configured to house the components described above. As described above with reference to FIG. 1A, which illustrates the detection device 100 in its assembled form, the top housing 120 includes a window that provides access to the heat-activated reservoir 170 of the integrated heating element.

[0105] The heating element substrate 410 includes a thermally activated reservoir 170 and a heating element cavity 865. A separation member 412 physically separates the thermally activated reservoir 170 from the heating element cavity 865. The separation member 412 physically separates the thermally activated reservoir 170 from the heating element cavity 865 so that introduction of an agent into the thermally activated reservoir 170 does not immediately contact the contents of the heating element cavity 865. The heating element substrate 410 also includes an overflow cavity 414. The overflow cavity 414 is configured to receive excess agent and / or gas that exceeds the volume of the heating element cavity 865. When the sheet 820 is bonded to the heating element substrate 410, one or more channels are formed between the grooves 416 of the heating element substrate 410 and the sheet 820. One or more channels allow any excess agent and / or gas to flow from the heating element cavity 865 to the overflow cavity 414 .

[0106] Wicking paper 850 is disposed within heating element substrate 410, with a first portion of wicking paper 850 positioned in heat-activated reservoir 170 and a second portion of wicking paper 850 positioned within heating element cavity 865. Wicking paper 850 includes a bridge portion 854 that extends above separating member 412 of the heating element substrate. Separating member 412 separates heat-activated reservoir 170 from heating element cavity 865 such that introduction of a heat-activated agent into heat-activated reservoir 170 does not immediately expose the contents of heating element cavity 865 to the heat-activated agent.

[0107] An exothermic heating material 840 is disposed within the heating element cavity 865. The exothermic heating material 840 is disposed above and in contact with the upper surface 852 of the wicking paper 850. At the start of a test event, a thermal activation agent is placed in the thermal activation reservoir 170 shown in FIG. 1A. The thermal activation agent may include a liquid, such as water, a buffer, or a reagent solution, a gas, a powder, or any other agent configured to activate the heat-generating component of the integrated heating element.

[0108] The thermal activation agent can be added to the thermal activation reservoir 170 manually by a user or by an automated system. The thermal activation agent can be added to the thermal activation reservoir 170 before or after the sample is added to the sample reservoir 212. In one non-limiting embodiment, the thermal activation agent is added to the thermal activation reservoir 170 a predetermined amount of time before the sample is added to the detection device 100, the predetermined amount of time being selected based on the time required for the heat-generating element to be activated and generate an appropriate or optimal amount of heat. In one example, the thermal activation agent is added 30 minutes, 25 minutes, 20 minutes, 15 minutes, 10 minutes, 5 minutes, 1 minute, 30 seconds, 10 seconds, 5 seconds, 1 second, or within a range defined by any two of the aforementioned values ​​before the fluid sample is added to the detection device 100.

[0109] The thermally activated agent received in the thermally activated reservoir 170 interacts with the portion of the wicking paper 850 disposed in the reservoir 170. In one example where the activator is a liquid, the wicking paper 850 absorbs the activator. The thermally activated agent flows along the wicking paper 850 or is drawn by the wicking paper 850 into the heating element cavity 865. The heating element 840, located within the heating element cavity 865 and in contact with the upper surface 852, interacts with the thermally activated agent in this portion of the wicking paper 850. When the thermally activated agent contacts the exothermic heating material 840, heat is generated. The heat generated in the exothermic heating material 840 is transferred to the sheet 820 disposed above the heating element substrate 410. The sheet 820 can be formed of a metal, such as, but not limited to, aluminum.

[0110] In this non-limiting example, the heating element includes a seal 830 disposed between the heating element substrate 410 and the sheet 820. The seal 830 may include an aluminum pressure-sensitive adhesive (PSA) configured to encapsulate the heating element 840 within a space formed between the heating element cavity 865 and the sheet 820. The heating element may also include a white background material 810 disposed above the sheet 820. The heating element may also include a layer 870 disposed below the heating element substrate 410. The layer 870 may form a bottom surface of the heating element cavity 865.

[0111] Exothermic heating material 840 can be positioned within heating element substrate 410 at locations directly beneath control wells 160, reagent wells 140, and test wells 150. As a result of this positioning, heat generated by exothermic heating material 840 is directed toward the fluid samples located in these wells, thereby increasing the temperature of the fluid samples. Advantageously, increasing the temperature of the fluid samples in this manner can increase the reaction rates in these wells, including the reaction rate of reducing agent 142 with the fluid samples, thereby shortening assay reaction times or providing ideal reaction temperatures without the need for external heating equipment.

[0112] The exothermic heating material can be any material capable of undergoing an exothermic chemical reaction upon contact with a heat-activating agent. For example, the exothermic heating material can include calcium oxide (CaO), magnesium (Mg), iron (Fe), calcium chloride (CaCl), or any combination thereof. The exothermic heating material can include a phase change material (PCM), such as sodium acetate (NaOCOCH), paraffin, other salt hydrates, fatty acids, or combinations thereof. The PCM can act as a buffer to prevent excessive heat generation.

[0113] Embodiments of detection devices implementing an integrated heating element can include a resistive heating element. Figures 8B and 8C show components of an exemplary integrated resistive heating element 880 implemented in a detection device 900 according to the present disclosure. The detection device 900 can include the same or similar components (such as the top substrate 210, bottom substrate 310, and associated components) of the detection device 100. Although not shown in Figures 8B and 8C, the detection device 900 can include the same or similar components (such as the top substrate 210, bottom substrate 310, and associated components) of the detection device 100. Figure 8B shows the resistive heating element 880 integrated into the bottom housing 110 of the detection device 900. The resistive heating element 905 includes one or more resistive heaters 910 that are positioned on a printed circuit board (PCB) directly beneath the control wells 160, reagent wells 140, and test wells 150 to generate heat at these specific locations to increase the temperature of the fluid samples in the control wells 160, reagent wells 140, and test wells 150. The resistive heating element 905 includes a power supply 920 that may include one or more battery holders and / or external power connections for providing power to the one or more resistive heating elements 910.

[0114] 8C depicts the resistive heating element 880 without the bottom housing 110. The resistive heating element 880 can be removable and / or reusable. For example, the resistive heating element 880 can be removed from the bottom housing 110 of a first detection device 900 and attached to the bottom housing 110 of a second detection device 900 after completion of a test event using the first detection device.

[0115] Advantageously, activation of the resistive heater 910 can generate controlled, instantaneous heat that is rapidly transferred to the test component. In one non-limiting example, the resistive heater 910 is activated immediately before or after the fluid sample is added to the detection device 900. For example, the resistive heater 910 can be activated 1 minute, 50 seconds, 40 seconds, 30 seconds, 20 seconds, 10 seconds, 5 seconds, or 1 second before or after adding the sample to the detection device 900.

[0116] Exemplary Detection Device Features The detection devices described herein include a device housing. Any housing of the detection devices described herein, including the top or bottom housing, can be made of any suitable material, including, for example, vinyl, nylon, polyvinyl chloride, polypropylene, polystyrene, polyethylene, polycarbonate, polysulfone, polyester, urethane, or epoxy. The housing can be prepared by any suitable method, including, for example, by injection molding, compression molding, transfer molding, blow molding, extrusion, foam molding, thermoforming, casting, layer deposition, or printing. In some embodiments, the top housing includes a viewing window for visualizing samples in the control and test wells. In some embodiments, the top housing includes a heat-activated reservoir or well. In some embodiments, the top housing includes a locking feature for coupling to a cap. In some embodiments, the bottom housing includes a gas vent. In some embodiments, the top and bottom housings include complementary posts and receptacles that complement each other and accommodate internal components of the detection device, such as a fluid flow path and, if implemented, a heating element.

[0117] Any cap of a detection device described herein can be made of any suitable material, including, for example, vinyl, nylon, polyvinyl chloride, polypropylene, polystyrene, polyethylene, polycarbonate, polysulfone, polyester, urethane, or epoxy. In some embodiments, the cap includes a flexible linker that can connect the cap to the top or bottom housing, allowing the cap to move from an open position ( FIG. 1A ) to a closed position ( FIG. 1B ). In some embodiments, the cap includes an outer lip that can lock into a locking feature to couple the cap to the detection device. In some embodiments, an interior feature of the cap includes a plunger configured to couple with a sample reservoir. The plunger is capable of removing excess fluid sample from the sample reservoir. Furthermore, upon closing the cap, the plunger is configured to generate sufficient pressure to drive or propel the fluid sample through the fluid flow path at a precise, predetermined volume. In some embodiments, the plunger includes a seal for coupling to the sample reservoir. In some embodiments, the cap further includes an outer seal that prevents fluid leakage from the detection device by retaining excess fluid in an overflow reservoir. In some embodiments, the plunger seal and / or the outer seal are elastomeric seals.

[0118] The detection devices described herein can include a sample reservoir through which a fluid sample is introduced into the fluid flow path. In one example, the sample may be introduced into the sample reservoir by external application, such as with a dropper or other applicator. The sample may be poured into the sample reservoir. In another example, the sample reservoir may be directly immersed in the sample. As described herein, the sample volume placed in the sample reservoir need not be an exact amount. Instead, an approximate volume of the fluid sample may be placed in the sample reservoir. When the cap of the detection device is closed, excess fluid sample is removed to an overflow reservoir, and a precise, predetermined volume of the fluid sample is propelled through the fluid flow path by pressure exerted by a plunger integrated into the cap. Thus, the detection device includes automatic measurement of the fluid sample. While the user is not required to measure the exact amount of the fluid sample, the user can instruct the user to add a minimum amount of fluid sample to the sample reservoir. For example, a fluid sample less than the minimum volume may be insufficient to flow the fluid sample through the entire flow path, thereby resulting in inaccurate test results. It will be understood that the detection device of the present disclosure can be shaped and sized to accept and test any suitable sample volume. In non-limiting examples, the volume of the sample configured to flow through the fluid flow path can range from about 100 μL to about 500 μL, such as 100, 125, 150, 175, 200, 225, 250, 275, 300, 325, 350, 375, 400, 425, 450, 475, or 500 μL, or an amount within a range defined by any two of the aforementioned values. Thus, the volume can range from microliters to submilliliters. This volume, in embodiments of the present disclosure, can be sufficient to completely fill the fluid flow path, control wells, reagent wells, and test wells. The volume of the fluid sample flows through the fluid flow path, displacing any inert gas or air present in the fluid flow path.The inert gas or air flows downstream in the direction of fluid flow through the fluid flow path, through the control well, through the one-way flapper valve, through the reagent well, through the test well, and through a gas vent that may contain a frit, and is thus vented out of the detection device.

[0119] Excess fluid sample (if any) flows into an overflow reservoir, with the excess fluid sample being received by the detection device and expressly contained within the detection device. The overflow reservoir can have a holding volume ranging from 0.1 mL to 5 mL, e.g., 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.5, 2, 5, 3, 5, 4, 4.5, or 5 mL, or an amount within a range defined by any two of these values. The holding volume of the overflow reservoir can be any volume suitable for receiving and holding the excess fluid sample and preventing leakage of the fluid sample from the detection device.

[0120] It will be understood that embodiments of the detection device according to the present disclosure can be implemented without a sample collection volume control feature. In one non-limiting example, the detection device of the present disclosure receives a sample volume in a sample reservoir that does not interact with an overflow reservoir, cap, or plunger.

[0121] Accordingly, some embodiments provided herein relate to detection devices having sample collection volume control features. In some embodiments, the sample collection volume control includes a sample reservoir having a specified sample volume, an overflow reservoir configured to capture excess fluid sample, and a plunger that 1) generates pressure to deliver a precise, predetermined volume of fluid sample through the assay fluid flow path and 2) ejects excess sample from the sample reservoir into an overflow container. Thus, delivery of a precise, predetermined volume is built into the dimensions of the detection device (including the shape, size, and volume of the sample reservoir and the shape, size, and volume of the plunger that interacts with the sample reservoir), eliminating or reducing user error.

[0122] In some embodiments, the fluid flow path includes a top substrate and a bottom substrate joined together in a precise manner to provide a single, integrated fluid flow path that transitions between the top and bottom substrates. The substrates can be made of any suitable material, including, for example, vinyl, nylon, polyvinyl chloride, polypropylene, polystyrene, polyethylene, polycarbonate, polysulfone, polyester, urethane, or epoxy. Components forming part of the fluid flow path, such as channels, junctions, and wells (e.g., control wells, reagent wells, and test wells), can be fabricated from the substrate material using known manufacturing techniques, such as injection molding, compression molding, transfer molding, blow molding, extrusion, foam molding, thermoforming, casting, additive manufacturing, laser imprinting, and printing. After fabrication of the substrate, portions of the fluid flow path (e.g., fluid channels and wells) partially embedded in the substrate are sealed using one or more layers adhered to the top and bottom surfaces of the substrate. The layers can include sealing films incorporated into the device using known methods, such as laser sealing, heat sealing, adhesives, and the like. The sealing film has a seal burst pressure sufficient to contain a sample within the fluid flow path at a pressure of up to 40 pounds per square inch (psi), which may be 10, 15, 20, 25, 30, 35, or 40 psi, or any amount within a range defined by any two of the aforementioned values. In some embodiments, the sealing film has sufficient transparency, including optical clarity, to allow colorimetric measurement of the fluid sample in the control and test wells or to be free of interference by a reader device. In some embodiments, the sealing film is 3M LF400M film (heat seal) or 3M 9982 film (pressure-sensitive adhesive). Other acceptable films may also be used that have desirable properties, such as high seal burst pressure, high transparency, compatibility with liquid samples containing reagents such as dyes and reducing agents, and fast seal cure times.

[0123] In some embodiments, the fluid flow paths are integrated into a single substrate, as opposed to a top and bottom substrate. In a single substrate, the fluid flow paths include junctions that allow the fluid flow paths to have either an up or down flow path, so that various wells, including control wells, reagent wells, and test wells, can be filled in a predetermined direction (bottom-up or top-down). The design of the fluid flow paths, whether on a single substrate or integrated across two or more substrates, offers several advantages, including first passing a fluid sample through the control well and then isolating the control zone (the fluid flow path upstream of the one-way flapper valve) from the test zone (the fluid flow path upstream of the one-way flapper valve) via a one-way flapper valve, preventing fluid from flowing from the test zone to the control zone. Samples that pass through the one-way flapper valve and enter the test zone cannot return to the control zone. The fluid flow paths also offer the advantage of filling wells from a specific direction, such as top-down or bottom-up.

[0124] Referring to FIG. 4A, a fluid sample is placed in a sample reservoir to solubilize the dye contained therein. The fluid sample can be any fluid sample having or suspected of having an analyte therein. The analyte of interest can include, for example, an anti-tumor agent such as cyclophosphamide, docetaxel, fluorouracil, ifosfamide, imatinib, or paclitaxel. The dye can include any dye capable of undergoing a detectable color change in the presence of the analyte of interest in combination with a reducing agent. For example, the dye can be Direct Red 2, Direct Red 7, Direct Red 13, Direct Red 53, Direct Red 75, Direct Red 80.D, Direct Red 81, Direct Fast Red B, methylene blue, methyl orange, crocetin scarlet 7B, Congo red, or an azo dye. In some embodiments, the reaction of the dye with the reducing reagent in the presence of the analyte clears the dye, causing a fluid sample with the dye to exhibit the intense color of the dye, while a fluid sample with the dye and the reducing agent containing the analyte exhibits the reduced color of the dye. In some embodiments, the dye is Direct Red 13 and the reducing agent is NaBH4. Without being bound by theory, in the presence of a platinum-containing reagent, the reducing agent forms platinum nanoparticles and reduces the dye. The dye reaction is based on the reduction of an azo bond, occurs at a slow rate, and is catalyzed in the presence of platinum nanoparticles. The reducing agent also reacts in the presence of water to produce hydrogen, resulting in gas accumulation in the reagent well, increasing the pressure in the reagent well, and propelling the liquid sample into the test well. The rate of the reaction can be varied based on the temperature of the assay. The temperature can be room temperature (or the ambient temperature at which the reaction is occurring) or at an elevated temperature. For example, the devices described herein can further include an integrated heating element, as described in more detail herein. Increasing the temperature increases the reaction of the reducing reagent with water, increasing the production of hydrogen.

[0125] Although embodiments of the detection device of the present disclosure are described as detecting platinum-based antitumor drugs, it will be understood that the present disclosure is not limited to this example. Detection device embodiments of the present disclosure can also detect other target analytes, such as palladium-based drugs (e.g., palladium(II) complexes with thiosemicarbazones), ruthenium-based drugs, and gold-containing drugs (e.g., auranifin, aurothioglucose, sodium aurothiosulfate, aurothiomalate disodium, aurothiomalate sodium, and various other drugs containing gold salts). Furthermore, while embodiments of the detection device of the present disclosure are described as implementing NaBH4 as a reducing agent, it will be understood that the present disclosure is not limited to this implementation. Detection device embodiments of the present disclosure can also implement other reducing agents, such as, but not limited to, borohydride-based reducing agents, LiAlH4, and Zn(BH4)2.

[0126] In some embodiments, the dye is dried onto the wall of the sample reservoir. In this embodiment, the solubilized dye can be at a concentration of 50-200 μM. It is understood that varying the volume and / or characteristics of the well and / or sample fluid will necessitate adjusting the level of dried and solubilized dye. For example, in a 100 μL sample reservoir with high dye release characteristics, 10 μL of 1000 mM dye can be dried to obtain a solution containing 100 mM dye. The fluid sample solubilizes the dye, and upon application of the plunger, the fluid sample with the solubilized dye begins to flow through the fluid channel. The fluid channel can include a mixing feature with irregularly shaped sidewalls and posts to promote mixing of the fluid sample and the dye. In some embodiments, the dye is added to the fluid sample before it enters the detection device. In another non-limiting example, the dye is added to the sample reservoir after the sample is added to the sample reservoir. The fluid sample flows along the flow path to the control well. Although non-limiting example flow paths are described in more detail above, it will be understood that alternative flow paths may be suitably implemented in embodiments of the present disclosure. The fluid sample in the control well exhibits a control color due to the presence of the dye, which can be measured visually by an operator or colorimetrically by a detector positioned to receive a light signal at the control well.

[0127] The embodiments of the detection device described herein include a one-way flapper valve in the fluid flow path. It will be understood that embodiments of the detection device of the present disclosure can be suitably implemented without a valve. A valve can also serve as a junction for transferring a fluid sample from the top substrate to the bottom substrate. In one non-limiting example, a one-way flapper valve includes a valve assembly having a flapper relief cavity that allows the fluid sample to flow only downstream through the one-way flapper valve. The one-way flapper valve can include a support ring and a moving flapper. The one-way flapper valve can be made of any suitable material, including, for example, vinyl, nylon, polyvinyl chloride, polypropylene, polystyrene, polyethylene, polycarbonate, polysulfone, polyester, urethane, or epoxy. In some embodiments, the one-way flapper valve is a hydrogel or other swellable material. After passing through the one-way flapper valve, the fluid sample remains on the downstream side of the one-way flapper valve and cannot move upstream (or reverse flow). In this manner, the one-way flapper valve is configured to prevent backflow of the fluid sample.

[0128] The fluid sample flows through a one-way flapper valve into the reagent well. The reagent well contains a reagent deposited therein. In some embodiments, the reagent is a reducing agent, such as NaBH4. The reducing agent can be dried into the reagent well during or after fabrication of the substrate. The amount of reducing agent dried in the reagent well can be an amount corresponding to 10 mM to about 1000 mM, such as 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, or 1000 mM, or an amount within a range defined by any two of the foregoing values. The fluid sample flows into the reagent well from the bottom, dissolving the reducing agent. If the analyte is present in the fluid sample, the dye reacts with the reducing agent, resulting in two distinct chemical reactions. The first chemical reaction is a color change of the dye, resulting in a test color that is distinct from the control color. The second chemical reaction is the generation of gas, which generates pressure and propels the fluid sample into the test well. The increased pressure of the gas generated in the reagent well fills the test well, allowing for a lower sealing pressure and preventing undesirable artifacts, such as air bubbles or debris, from entering the test well. These artifacts can cause abnormalities in the signal measurement in the test well, and eliminating the artifacts improves measurement accuracy. Therefore, gas generation in the reagent well reduces artifacts, such as air bubble formation in the test well, thereby improving the color measurement of the fluid sample in the test well. To prevent air bubble adhesion in the test well, methods such as plasma-treating the test well walls and surface-modifying the substrate can be used to reduce air bubble adhesion in the test well. On the other hand, the reagent well is not plasma-treated, which promotes air bubble adhesion in the reagent well. As a result, the gas in the reagent well expands in volume, forcing the fluid sample into the test well without bubbles, resulting in a clear test well that improves imaging of the fluid sample.The reagent well is filled from bottom to top with the fluid sample.

[0129] In embodiments of the present disclosure, gas or air that filled the entire fluid flow path prior to placing fluid in the fluid flow path is forced into the fluid flow path through a gas vent downstream of the test well. The gas vent can include a self-sealing frit, such as a Porex® frit, that allows the passage of gas, such as air, present in the fluid flow path. If excess fluid sample escapes from the test well into the gas vent, the frit in the gas vent is configured to prevent the flow of fluid sample beyond the gas vent into the surrounding atmosphere. In some embodiments, the Porex® frit is Porex® 5422 35 μm polyethylene self-sealing material.

[0130] The flow of sample from the sample reservoir through the entire flow path to the reagent wells is achieved by the placement of the cap on the sample reservoir, as a plunger in the cap generates pressure that propels a specific, predetermined volume of fluid sample through the flow path. Upon reaching the reagent well, the sample comes into contact with a reducing agent, generating gas. This gas generation increases the pressure in the reagent well. A one-way flapper valve prevents the fluid sample from flowing upstream and allows it to flow in one direction toward the test wells, preventing or reducing the formation of air bubbles. At this time, the fluid sample in the control wells exhibits a control color, and the fluid sample in the test wells exhibits a test color. If an analyte is present in the fluid sample, the control color and the test color are simultaneously displayed. The control color in the control wells and the test color in the test wells can be measured colorimetrically or optically, such as visually or by a reader device, to determine whether the colors in the control wells and the test wells are the same or different. If the colors are determined to be different, this indicates the presence of the analyte in the fluid sample, and if the colors are determined to be the same (or within a preset range of color change), this indicates the absence of the analyte in the fluid sample. If the colors are determined to be different, the degree of difference can be measured to determine the amount of analyte present in the sample.

[0131] The control and test wells are visible through an observation window in the upper housing so that the control and test wells can be measured after the fluid sample has flowed through the detection device. Measurements can be made by visual inspection of the color in the control and test wells or by placing the detection device in a reader device that can measure an optical property (e.g., color, absorbance, transmittance, reflectance, etc.) in the control and test wells. In some embodiments, the reader device is configured to compare the reflectance or absorbance signal in the control wells with the reflectance or absorbance signal in the test wells and generate a value indicative of the difference between the signal from the control wells and the signal from the test wells. In some embodiments, the reader device is capable of quantifying the amount of analyte present in the fluid sample based on the difference between the signal in the control wells and the signal in the test wells.

[0132] In some embodiments, the detection device further includes a heating element. In some embodiments, the heating element is a chemical heating element or a resistive heating element. In some embodiments, the heating element is an integrated heating element positioned within the housing directly below the fluid flow path in a location that can specifically regulate the temperature of the fluid sample in the control well, reagent well, and test well. It will be understood that other spatial arrangements can be implemented, such as locating the heating element above or laterally adjacent to the fluid flow path. In some embodiments, the heating element regulates the temperature of the fluid sample to reduce assay reaction time or to provide an ideal reaction temperature.

[0133] In some embodiments, the heating element is a chemical heating element. In embodiments where the heating element is a chemical heating element, the upper housing includes a heat-activated reservoir configured to receive an activator capable of activating an exothermic reaction. The activator can be any agent capable of activating an exothermic reaction, such as air, water, a buffer, or a fluid. The activator is deposited in the heat-activated reservoir and contacts the chemical heating element, thereby generating an exothermic reaction, increasing the temperature of the chemical heating element and, in turn, increasing the temperature of the fluid sample flowing through the fluid flow path. In some embodiments, the activator is deposited in the heating element reservoir. In some embodiments, a wicking layer (such as wicking paper) is deposited in the heating element reservoir. The wicking paper is made of any suitable material capable of wicking the heat-activated agent to the chemical heating element in a controlled manner, thereby controlling the reaction rate. For example, the wicking paper can be a cellulosic material, a paper substrate, a fibrous material, or other suitable material. In some embodiments, the wicking paper has a portion located within the heating element reservoir and a bridge portion extending over a separator member separating the heating element reservoir from the heating element cavity, and the activator flows through the wicking paper, over the bridge portion, and into the heating element cavity where it contacts the chemical heating element, thereby activating the exothermic reaction.

[0134] The chemical heating element can be made of any suitable material capable of generating an exothermic reaction. For example, the chemical heating element can include calcium oxide, magnesium, iron, calcium chloride, sodium acetate, or combinations, salts, or derivatives thereof. For example, magnesium hydroxide is a thermodynamic heat source, and the presence of sodium chloride and iron kinetically enhances the reaction rate sufficient to generate heat. In some embodiments, the chemical heating element further includes a phase change material (PCM) that acts as a buffer to prevent the reaction temperature from increasing excessively.

[0135] The chemical heating element can generate heat in an amount greater than about 0.2 kJ / g to about 30 kJ / g, such as greater than 0.2, 0.4, 0.6, 0.8, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, or 30 kJ / g, or within a range defined by any two of the aforementioned values. In some embodiments, the chemical heating element includes calcium oxide, which reacts with water to produce a heat output of about 1.15 kJ / g. In some embodiments, the chemical heating element includes a magnesium / iron alloy, which reacts with water to produce a heat output of about 14.52 kJ / g. The magnesium / iron alloy can have a magnesium to iron ratio of 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, 5:1, 2:3, 2:5, 3:2, 5:2, or within a range defined by any two of the foregoing values. In some embodiments, the chemical heating element includes calcium chloride, which reacts with water to produce a heat output of approximately 0.73 kJ / g. In some embodiments, the chemical heating element includes iron plus salt, which reacts with oxygen and / or water to produce a heat output of approximately 29.52 kJ / g. In some embodiments, the PCM includes sodium acetate and / or paraffin, which melts or solidifies to control or suppress the temperature rise. The ratio of Mg / Fe alloy to chemical heating element, such as PCM, can be varied, such as 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1, 5:1, 2:3, 2:5, 3:2, 5:2, or amounts within a range defined by these two values. Other chemical heating elements may also be used.

[0136] In some embodiments, the chemical heating element further comprises an aluminum pressure sensitive adhesive (PSA), an aluminum sheet, and / or a heat dissipating material to control and / or conduct heat to the appropriate location in the fluid flow path. In some embodiments, the chemical heating element further comprises an overflow cavity through which excess activator may flow, and may further comprise vents to allow for the evacuation of air or gas from the chemical heating element.

[0137] In some embodiments, the heating element is one or more resistive heating elements. The resistive heating elements are housed within the detection device housing in a position directly below the fluid flow path. It will be understood that other spatial arrangements are possible, such as locating the heating elements above or laterally adjacent to the fluid flow path. The resistive heating elements can include a printed circuit board (PCB) having the resistive heating elements printed thereon and positioned directly below the control well, reagent well, and test well. A power source configured to provide current to the resistive heaters can be housed within the same housing as the PCB or can be located external to the housing. The power source can be, for example, a small coin cell battery or an external power source. The heaters on the PCB can be activated in several ways, including, for example, by placing a cap on the sample reservoir, opening the packaging, manually flipping a mechanical switch, or by a mechanical switch activated during user action by closing conductive traces on the PCB when the device is filled with a fluid sample (e.g., the fluid conductivity of the fluid sample establishes an electrical path). In one embodiment, the resistive heating element is a single-use device that is deployed after the detection device is activated. In another embodiment, the resistive heating element is removably received in the detection device such that it can be removed after the detection device is activated and reused in multiple detection devices for generating heat in multiple devices.

[0138] In some embodiments, the heating element generates heat capable of raising the temperature of the fluid sample in the fluid flow path to a temperature in a range of about 20°C to about 60°C, such as 20, 25, 30, 35, 40, 45, 50, 55, or 60°C, or a temperature within a range defined by any two of the aforementioned values. In some embodiments, the heating element raises the temperature of the fluid sample within a time period ranging from about 1 minute to about 10 minutes, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 minutes, or a time period within a range defined by any two of the aforementioned values. In some embodiments, the heating element is configured to maintain the temperature of the fluid sample for a time period ranging from about 5 minutes to about 60 minutes, such as 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, or 60 minutes, or a time period within a range defined by any two of the aforementioned values. In some embodiments, the increase in temperature of the fluid sample does not affect the sensitivity of a detection means, such as visual detection of a signal in the control and test wells, or a reader device. An advantage of the heating element is that it provides an internal heating source integrated into the detection device, thereby avoiding the need for an external heating source such as a secondary heating device or an incubation oven. Furthermore, by having an internal heating element as described herein, the detection device can retain the existing size and shape of conventional or standard detection devices, and there is no need to modify the reader device to be able to read the results of an assay performed on the detection device.

[0139] (Examples of methods for detecting analytes) Embodiments provided herein relate to methods for detecting an analyte in a fluid sample using the detection devices provided herein. In some embodiments, the analyte is a drug to be detected obtained from an environmental source. In some embodiments, the analyte is a harmful contaminant obtained from an environmental source. The analyte can be obtained from any surface found in any environment where analytes are typically found or suspected to be found. For example, the analyte can be an analyte found in a hospital, healthcare, clinical, research, pharmaceutical, forensic, or industrial environment. The analyte can be an analyte found in a domestic or residential environment. The analyte can be obtained from surfaces found in a hospital, medical facility, clinic, research facility, or pharmacy, such as benches, desks, counters, cabinets, walls, floors, windows, implements (such as, but not limited to, dispensing hoods), equipment (such as refrigerators and freezers), tables, chairs, toilets, and bed surfaces (including surfaces or handles associated with any of the above places and objects) found in the environment. The above list of analytes is exemplary and not exhaustive. The analyte can be measured by a user who collects the amount of analyte, or the analyte can be obtained by an upstream user who can provide the analyte to an operator who measures the analyte in the sample.

[0140] Analyte is 1,5,10,15,20,25,30,35,40,45,50,55,60,65,70,75,80,85,90,95,100,120,130,140,150,160,170,180,190,200,210,220,230,240,250,260,270,280,290,300,310,320,330,340,350,360,370 It can be present in a sample in an amount ranging from less than 1 nM to more than 1000 nM, such as less than 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 490, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, or 1000 nM, or within a range defined by any two of the above values.

[0141] As used herein, "analyte" generally refers to a substance to be detected. For example, analytes can include antigenic substances, haptens, antibodies, and combinations thereof. Analytes of interest include, but are not limited to, anti-tumor agents, gold salts, steroids, toxins, organic compounds, proteins, peptides, microorganisms, amino acids, nucleic acids, hormones, steroids, vitamins, drugs (both therapeutically and illicitly administered), drug intermediates or by-products, bacteria, virus particles, metabolites or antibodies to any of the above substances. Drugs of intoxication and controlled substances include, but are not limited to, barbiturates such as amphetamine, methamphetamine, amobarbital, secobarbital, pentobarbital, phenobarbital, and barbital; benzodiazepines such as librium and valium; cannabinoids such as hashish and marijuana; cocaine; fentanyl; LSD; methaqualone; opiates such as heroin, morphine, codeine, hydromorphone, hydrocodone, methadone, oxycodone, oxymorphone, and opium; phencyclidine; and propoxyphene. Additional analytes can be included as targets for biological or environmental substances of interest. It will be understood that embodiments of the present disclosure can be implemented to detect any suitable analyte of interest.

[0142] In some embodiments, the analyte of interest is an anti-tumor agent. As used herein, the term "anti-tumor agent" has its ordinary meaning as understood in light of the present specification and refers to an agent that has the functional property of inhibiting the development or progression of malignant (cancerous) lesions such as neoplasms, particularly carcinomas, sarcoid tumors, or leukemias in humans. Inhibition of metastasis is often a property of an anti-tumor agent.In some embodiments, the analyte of interest is selected from the group consisting of afatinib, aflibercept, alemtuzumab, alitretinoin, altretamine, anagrelide, arsenic trioxide, asparaginase, axitinib, azacitidine, BCG vaccine, bendamustine, bevacizumab, bexarotene, bosutinib, bleomycin, bortezomib, busulfan, cabazitaxel, capecitabine, carboplatin, carmofur, carmustine, cetuximab, chlorambucil, cisplatin, cladribine, clofarabine, and crizotinib. cyclophosphamide, cytarabine, dacarbazine, dactinomycin, dasatinib, daunorubicin, decitabine, denileukin diftitox, denosumab, docetaxel, doxorubicin, epirubicin, erlotinib, estramustine, etoposide, everolimus, floxuridine, fludarabine, fluorouracil, fotemustine, gefitinib, gemcitabine, gemtuzumab ozogamicin, hydroxycarbamide, ibritumomab tiusetan, idarubicin, ifosfamide, imatinib, Ipilimumab, irinotecan, isotretinoin, ixabepilone, lapatinib, lenalidomide, lomustine, melphalan, mercaptopurine, methotrexate, mitomycin, mitcoxantrone, nedaplatin, nelarabine, nilotinib, ortum, nivolumab, ofatumumab, oxaliplatin, paclitaxel, panitumumab, panobinostat, pazopanib, pembrolizumab, pemetrexate, pentostatin, pertuzumab, pomalidomide, ponatinib, procarbazine, raltitrexed , regorafenib, rituximab, romidepsin, ruxolitinib, sorafenib, streptozotocin, sunitinib, tamibarotene, tegafur, temozolomide, temsirolimus, teniposide, thalidomide, thioguanine, topotecan, tositumomab, trastuzumab, tretinoin, valproic acid, valtube, vandetanib, vemurafenib, vinblastine, vincristine, vindesine, vinflunine, vinorelbine, or vorinostat, or a derivative, conjugate, or analog thereof.

[0143] In some embodiments, the analyte is a steroid, hi some embodiments, the steroid is a glucocorticoid, such as hydroxycortisone, cortisone, desoxycorticosterone, fludrocortisone, betamethasone, beclomethasone, dexamethasone, prednisolone, prednisone, methylprednisolone, paramethasone, triamcinolone, flumethasone, fluocinolone, fluocinonide, fluprednisolone, halcinonide, flurandrenolide, meprednisone, medrysone, clobetasol, and esters, mixtures, analogs, or derivatives thereof.

[0144] In some embodiments, the analyte is a toxin. As used herein, the term "toxin" has its ordinary meaning as understood in light of the present specification and refers to an agent that is toxic to living cells or organisms. Toxins include, for example, small molecules, peptides, or proteins, and can include biological or environmental toxins.

[0145] In some embodiments, the analyte is a pesticide. As used herein, the term "pesticide" has its ordinary meaning as understood in light of the present specification and refers to an agent or drug for controlling pests. Pesticides can include, for example, algicides, antifouling agents, antibacterial agents, attractants, biological pesticides, fungicides, disinfectants, fumigants, herbicides, insecticides, acaricides, microbial pesticides, molluscicides, nematicides, ovicides, pheromones, repellents, or rodenticides.

[0146] In some embodiments, the analyte is a biological warfare agent and can include, for example, a biological toxin, an infectious agent such as a bacterium, virus, or fungus, or other agent intended to kill or harm a biological organism such as a human, animal, or plant.

[0147] In some embodiments, the analyte is obtained from a test surface using a collection device. As described herein, a test surface is any surface on which any analyte of interest as described herein can be obtained or on which any analyte is suspected to be found. In non-limiting examples, the test surface can be the surface of any object found in a hospital, medical facility, clinic, research facility, or pharmacy. In some embodiments, the test surface is a bench, desk, counter, cabinet, wall, floor, window, instrument, table, chair, toilet, or bed surface found in the environment.

[0148] In some embodiments, the analyte is obtained using a collection kit that can include, for example, a buffer configured to solubilize, transport, or remove the analyte from the test surface when the buffer is applied to the test surface, and an absorbent swab material configured to absorb at least a portion of the buffer and contact the test surface to collect the analyte. In some embodiments, the absorbent swab material is coupled to a first end of a handle. In some embodiments, the handle has a second end spaced from the first end and an elongated length extending therebetween. In some embodiments, the collection kit further includes a fluid-sealed container having an interior volume dimensioned to enclose the handle, the absorbent swab material, and the buffer, the container having a nozzle including an orifice dimensioned to provide controlled release of an amount of buffer from the interior volume. In one non-limiting example, an operator dispenses a volume of buffer from the container into a sample reservoir of a detection device of the present disclosure.

[0149] In some embodiments, a collected fluid sample having or suspected of having an analyte in the fluid sample is deposited in any one of the detection devices described herein in a sample reservoir. The volume of the fluid sample deposited in the sample reservoir does not need to be measured before depositing the fluid sample in the sample reservoir. A user can deposit the fluid sample into the sample reservoir to completely fill it. In some embodiments, closing the cap of the detection device activates a plunger located on the cap, which propels a precise, predetermined volume of the fluid sample through the fluid flow path of the detection device. Simultaneously, excess fluid sample that does not flow through the fluid flow path is forced into an overflow reservoir. In some embodiments, closing the cap activates a mechanical switch on a resistive heating element, thereby simultaneously activating the resistive heating element to initiate the detection assay.

[0150] In some embodiments, the method further includes measuring a control signal in a control well of the detection device and measuring a test signal in a test well of the detection device. In some embodiments, the measurement may be performed visually by visually inspecting the color in the control well and the color in the test well; when the colors in the control well and the test well are the same, the analyte is not present in the fluid sample, while when the colors in the control well and the test well are different from each other, the analyte is present in the fluid sample. In some embodiments, the measurement may be performed using a reader device. The reader device may include any reader device capable of receiving any one of the detection devices provided herein. The reader device may be capable of qualitative or quantitative measurement of the analyte in the fluid sample. A qualitative measurement may include determining whether the analyte is present in the sample. A quantitative measurement may include determining how much of the analyte is present in the sample. The devices, methods, and systems described herein may be used in a variety of applications, including: The reader can detect and quantify analytes present in amounts ranging from about 1 nM to about 1000 nM, such as 350, 360, 370, 380, 390, 400, 410, 420, 430, 440, 450, 460, 470, 480, 490, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, or 1000 nM, or amounts within a range defined by any two of the foregoing values. The reader can be a conventional reader and can be performed at a point-of-care laboratory or an off-site laboratory.

[0151] In some embodiments, the measurement of dye in the control and test wells is performed within a time period of less than 1 minute to less than 60 minutes after placement of the fluid sample in the detection device, such as less than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, or 60 minutes, or within a range defined by any two of the foregoing values. This time period can be shortened if the detection device has an integrated heating element.

[0152] (Test system example) The detection device test systems described herein can include any one of the detection devices described herein, a system housing including a port configured to receive all or a portion of the detection device, a reader including a light source and a photodetector, a data analyzer, and combinations thereof. The system housing can be made of any of a variety of materials, including plastic, metal, or composite materials. The system housing forms a protective enclosure for the components of the detection device test system. The system housing also defines a receptacle for mechanically registering the detection device with the reader. The receptacle can be designed to accept any one of a variety of different types of detection devices. In some embodiments, the system housing is a portable device, enabling the ability to perform detection assays in a variety of environments, such as on the bench, in the field, at home, or in residential, commercial, or environmental facilities.

[0153] The reader may include one or more optoelectronic components for optically inspecting the control and test wells through a viewing window in the detection device. In some embodiments, the reader includes at least one light source and at least one photodetector. In some embodiments, the light source may include a semiconductor light-emitting diode, and the photodetector may include a semiconductor photodiode. Depending on the nature of the dye used in the detection device, the light source may be designed to emit light within a specific wavelength range or with a specific polarization. For example, the dye may be a colorimetric dye, a fluorescent dye, or a reflectance dye. Examples of dyes include Direct Red 2, Direct Red 7, Direct Red 13, Direct Red 53, Direct Red 75, Direct Red 80, Direct Red 81, Direct Fast Red B, methylene blue, methyl orange, crocetin scarlet 7B, or Congo Red. Various azo dyes may be suitable. Each type of dye has different solubility and concentration, as well as a range of interaction with the reaction, and it will be understood that the amount and solubility of the selected dye can be optimized in the implementation of the detection device of the present disclosure. The dye is configured to be one color and, upon contact with a reducing agent, changes color to a second color in the presence of the analyte. For these purposes, the photodetector can include one or more optical filters that define the wavelength range or polarization axis of the captured light. The signal from the dye can be analyzed by visual observation or using a spectrophotometer to detect color in the control and test wells, or by using a colorimeter or fluorometer to detect fluorescence in the presence of certain wavelengths of light. The detection devices described herein can be automated or robotic, if desired, and can simultaneously detect signals from multiple samples in multiple detection devices.

[0154] The data analyzer processes measurements of the signals obtained by the reader. Generally, the data analyzer can be implemented in any computing or processing environment, including digital electronic circuitry, or computer hardware, firmware, or software. In some embodiments, the data analyzer includes a processor (e.g., a microcontroller, microprocessor, or ASIC) and an analog-to-digital converter. The data analyzer can be integrated within the housing of the diagnostic test system. In other embodiments, the data analyzer is located in a separate device, such as a computer, that can communicate with the diagnostic test system via a wired or wireless connection. The data analyzer can also include circuitry for transferring results to an external source via a wireless connection for data analysis or to confirm the results.

[0155] The test system can include a result indicator. Generally, the result indicator can include any one of a wide variety of different mechanisms for indicating one or more results of the assay test. In some embodiments, the result indicator includes one or more lights (e.g., light emitting diodes) that are activated, for example, to indicate the completion of the assay test. In other embodiments, the result indicator includes an alphanumeric display (e.g., a two- or three-character light emitting diode array) for displaying the results of the assay test.

[0156] The test systems described herein may include a power supply that provides power to the active components of the diagnostic test system, including the reader, data analyzer, result indicator, and / or heating element (where the heating element is a resistive heating element). The power supply may be implemented, for example, by a replaceable or rechargeable battery. In other embodiments, the diagnostic test system may be powered by an external host device (e.g., a computer connected via a USB cable).

[0157] The following non-limiting examples illustrate features of the detection devices, test systems, and methods described herein and are not intended to limit the scope of the present disclosure. [Example]

[0158] Preparation of a detection device according to the present disclosure The following example illustrates the preparation of a detection device according to the present disclosure for determining an analyte present in an environmental sample. In this non-limiting example, the analyte is a platinum-based anti-tumor drug.

[0159] The detection device is prepared by providing a top substrate and a bottom substrate, each having a fluid flow path integrated therein. The top substrate and the bottom substrate are configured to be bonded to each other so that the fluid flow paths are fully integrated into a single fluid flow path through the top substrate and the bottom substrate. The top substrate and the bottom substrate are bonded together by ultrasonic welding. The top substrate includes a sample reservoir. A dye is deposited in the sample reservoir and allowed to dry within the sample reservoir. The bottom substrate is prepared with a control well, a flapper valve assembly, a reagent well, a test well, and a gas vent. The reagent well is prepared with a reducing agent attached and allowed to dry within the reagent well. To prepare the reducing agent as a dry reagent, sodium borohydride granules are dissolved in dry acetonitrile using ultrasonic waves. This acetonitrile is delivered to the reagent well, and the solvent is removed by flushing with dry nitrogen. The dry amount of sodium borohydride added to the reagent reservoir corresponds to a liquid concentration of 20 mM to 40 mM. The gas outlet is provided with a frit, and the test well is plasma treated to modify the surface of the test well to reduce adhesion of air bubbles to the sidewall of the test well.

[0160] The top and bottom layers are heat-sealed to the surfaces of the top and bottom substrates as described herein. The top and bottom layers can comprise films, such as transparent films. A white background can be placed beneath the control and test wells, between the bottom substrate and the bottom layer, to provide a uniform white background for improved signal detection.

[0161] After the fluid flow paths are assembled, the heating element is inserted or added to the bottom housing, the fluid flow paths are inserted above the heating element, the cap with the plunger is inserted into the bottom housing, and the top housing is attached to the bottom housing. [Example]

[0162] (Detection of an analyte using a detection device) The following example illustrates the use of the detection device described in Example 1 to detect environmental pollutants.

[0163] Environmental contaminants are captured from environmental sources using a collection device. Briefly, environmental contaminants present in a hospital or pharmacy environment are obtained by contacting a test surface with a buffer solution. After a short incubation period, the buffer solution on the test surface is absorbed onto an absorbent cotton swab. The swab is then inserted into a sealed container. The solution is then transferred to the sample reservoir of the detection device, and the cap of the detection device is inserted over the sample reservoir.

[0164] If the detection device includes a chemical heating element, an activating agent (water, buffer, or other suitable fluid) is injected into the thermally activated reservoir. If the detection device includes a chemical heating element, an activating agent (water, buffer, or other suitable fluid) is injected into the thermally activated reservoir, activating the chemical heating element. If the detection device includes a resistive heating element, by way of example, placing a cap on the sample reservoir activates the resistive heating element. If a heating element is present, the heating element may be activated before or after the solution is transferred to the sample reservoir. The heating element may be activated before or after the solution is transferred to the sample reservoir.

[0165] The detection device is placed in a reader device, the signals in the control and test wells are measured, and the signals are compared, and a determination is made of the presence and / or amount of analyte in the liquid sample.

[0166] It will be understood that the description, specific examples, and data, while indicating exemplary embodiments, are given by way of illustration and are not intended to limit the various embodiments of the present disclosure. Various changes and modifications within the present disclosure will become apparent to those skilled in the art from the description and data contained herein and, therefore, are considered part of the various embodiments of the present disclosure.

Claims

1. 1. A detection device for detecting an analyte in a fluid sample, comprising: a sample reservoir in fluid communication with the fluid flow path; The fluid flow path is a control well downstream of the sample reservoir; a valve assembly downstream of the control well; a reagent well downstream of the valve assembly and having a dry reducing agent; a test well downstream of the reagent well; a detection device.

2. The device of claim 1 , wherein the reducing agent is configured to react with a detection dye in the presence of the analyte to initiate a color change.

3. 10. The device of claim 1, wherein the reducing agent is configured to generate a gas in the reagent well when the analyte is present in the fluid sample, the gas generated in the reagent well being configured to propel the fluid sample from the reagent well to the test well.

4. 4. The device of claim 3, wherein the valve assembly includes a one-way valve configured to allow the fluid sample and gas generated in the reagent well to travel from the reagent well toward the test well and to prevent the fluid sample and gas generated in the reagent well from traveling upstream of the one-way valve.

5. The device of claim 1 , wherein the sample reservoir contains a detection dye dried therein.

6. 6. The device of claim 5, wherein the detection dye is configured to solubilize in the fluid sample when the fluid sample is added to the sample reservoir, and the reducing agent is configured to react with the solubilized detection dye when the analyte is present in the fluid sample.

7. 6. The device of claim 5, wherein the fluid flow path comprises a mixing feature downstream of the sample reservoir, the mixing feature comprising a plurality of posts disposed in the fluid flow path, the plurality of posts configured to promote mixing of the fluid sample and the detection dye when the fluid sample is added to the sample reservoir.

8. 6. The device of claim 5, wherein the detection dye is Direct Red 2, Direct Red 7, Direct Red 13, Direct Red 53, Direct Red 75, Direct Red 80, Direct Red 81, Direct Fast Red B, methylene blue, methyl orange, crocetin scarlet 7B, Congo red, or an azo dye.

9. The device of claim 1 , wherein the analyte is a platinum-based anti-tumor drug.

10. 10. The device of claim 9, wherein the platinum-based anti-tumor drug comprises cisplatin, carboplatin, oxaliplatin, nedaplatin, triplatin tetranitrate, ormaplatin, phenanthriplatin, picoplatin, piriplatin, or satraplatin, or an analog or derivative thereof.

11. The device of claim 1 , further comprising an overflow reservoir concentrically disposed around the sample reservoir.

12. The device of claim 1 further comprising a cap, the cap including an outer seal and an activation plunger having an inner seal.

13. 13. The device of claim 12, wherein the activation plunger is configured to sealably mate with the sample reservoir and to propel a predetermined volume of fluid sample through the fluid flow path.

14. The reducing agent is NaBH 4 2. The device of claim 1, wherein:

15. 10. The device of claim 1, further comprising a gas vent downstream of the test well, the gas vent configured to allow gas within the fluid flow path to be vented from the device after the fluid sample is added to the sample reservoir and begins to flow in the fluid flow path.

16. 16. The device of claim 15, wherein the gas vent comprises a frit configured to seal against the passage of gas and the fluid sample in the presence of the fluid sample.

17. 10. The device of claim 1, further comprising a top substrate including a portion of the fluid flow path and a bottom substrate including a portion of the fluid flow path, the fluid flow path further comprising a plurality of junction points when the top substrate is bonded to the bottom substrate, the plurality of junction points configured to move the fluid sample between the top substrate and the bottom substrate as fluid flows from the sample reservoir to the test well.

18. 10. The device of claim 1, further comprising a housing including an observation window positioned above an upper surface of the test well and an upper surface of the control well, wherein when the analyte is present in the fluid sample, an optical signal read from the test well through the observation window is different from an optical signal read from the control well through the observation window.

19. 20. The device of claim 18, further comprising a heating element substrate including a heat-activated reservoir, the upper surface of the heat-activated reservoir being approximately flush with the upper surfaces of the test well and the control well, the housing further including an access window positioned above the upper surface of the heat-activated reservoir, the heat-activated reservoir being configured to receive an activating agent through the access window.

20. 20. The device of claim 19, wherein the heating element substrate further comprises a heating element cavity located below the test well and the control well, the heating element cavity comprising an exothermic heating material configured to generate heat when exposed to the activating agent added to the thermally activated reservoir.

21. 21. The device of claim 20, further comprising wicking paper including a first portion positioned in the heat-activated reservoir and a second portion positioned in the heating element cavity, the wicking paper configured to wick at least a portion of the activator added to the heat-activated reservoir into the heating element cavity.

22. 21. The device of claim 20, wherein the heat-activated agent is air, water, a buffer, or a fluid, and the exothermic heating material comprises magnesium, iron, calcium chloride, calcium oxide, sodium acetate, paraffin, salt hydrates, fatty acids, or combinations thereof.

23. 10. The device of claim 1, further comprising a resistive heating element including a printed circuit board and an external power connector, the printed circuit board including a plurality of resistive heaters positioned below the reagent wells, the test wells, and the control wells.

24. 1. A method for detecting an analyte in a fluid sample, comprising: applying a fluid sample to a sample reservoir of a detection device, the detection device being in fluid communication with a fluid flow path including a control well downstream of the sample reservoir, a valve assembly downstream of the control well, a reagent well downstream of the valve assembly and having a dried reducing agent, and a test well downstream of the reagent well; solubilizing a detection dye in the sample reservoir in the fluid sample; coupling a cap to the sample reservoir to propel the fluid sample and the detection dye through the fluid flow path, wherein the fluid sample and the solubilized detection dye flow sequentially to the control well, the valve assembly, and the reagent well; generating a gas in the reagent well when the analyte is present in the fluid sample, the gas generated in the reagent well propelling the fluid sample from the reagent well to the test well; A method comprising:

25. 25. The method of claim 24, wherein a reducing agent in the reagent well reacts with the solubilized detection dye in the fluid sample in the presence of an analyte in the fluid sample to initiate a color change in the fluid sample detectable in the test well.

26. 25. The method of claim 24, further comprising mixing the fluid sample and the detection dye using a mixing feature located in the fluid flow path downstream of the sample reservoir.

27. measuring a control signal in the control well; measuring a test signal in the test well; indicating to a user that the analyte is not present in the fluid sample based on a determination that the control signal and the test signal are substantially the same; 25. The method of claim 24, further comprising:

28. measuring a control signal in a control well; measuring a test signal in the test well; indicating to a user that the analyte is present in the fluid sample based on a determination that the control signal and the test signal are different; 25. The method of claim 24, further comprising:

29. 29. The method of claim 28, wherein the control signal is an optical signal having a first color and the test signal is an optical signal having a second, different color, and the fluid sample emits the optical signal having the second, different color as a result of reduction of the detection dye in the presence of the reducing agent and the analyte.

30. 30. The method of claim 29, wherein the detection dye is configured to change from the first color to the second, different color in the presence of the reducing agent and the analyte.

31. The reducing agent is NaBH 4 25. The method of claim 24, wherein:

32. 25. The method of claim 24, wherein the fluid sample is applied to the sample reservoir in a volume of 100 to 500 μL.

33. 25. The method of claim 24, wherein the fluid sample is applied to the sample reservoir in a volume of about 250 μL.

34. 25. The method of claim 24, wherein the analyte is a platinum-based anti-tumor drug.

35. 35. The method of claim 34, wherein the platinum-based anti-tumor drug comprises cisplatin, carboplatin, oxaliplatin, nedaplatin, triplatin tetranitrate, or ormaplatin, phenanthriplatin, picoplatin, piriplatin, or satraplatin, or an analog or derivative thereof.

36. 25. The method of claim 24, further comprising heating the reagent wells and the test wells with heating elements positioned below the reagent wells and the test wells.

37. 37. The method of claim 36, wherein heating the reagent wells and the test wells comprises exposing exothermic heating material disposed beneath the reagent wells and the test wells to a heat-activated agent.

38. 38. The method of claim 37, further comprising adding the thermally activated agent to a thermally activated reservoir of the detection device and transferring the thermally activated agent from the thermally activated reservoir to a cavity containing an exothermic heating material.

39. 25. The method of claim 24, further comprising obtaining or obtaining a fluid sample from a surface contaminated or suspected to be contaminated with the analyte.

Images